Drug-induced neutropenia

DRUGADVERS_NEUTROPENIA

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D70.82# 1 out of 7 registries used, show all original rules.	2790
4. Check minimum number of events None	2790
5. Include endpoints None	2790
6. Filter based on genotype QC (FinnGen only)	2713

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: C
First used in FinnGen datafreeze: DF5

NAME	DRUGADVERS_NEUTROPENIA
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D7082
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Drug-induced neutropenia based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	12860	7872	4919
Only index persons	11777	7306	4471
Unadjusted period prevalence (%)
Whole population	0.19	0.23	0.14
Only index persons	0.23	0.27	0.17
Median age at first event (years)
Whole population	63.94	62.61	66.05
Only index persons	63.92	62.58	66.11

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2713	1730	983
Unadjusted period prevalence (%)	0.55	0.61	0.45
Median age at first event (years)	62.94	60.61	67.06

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2790: Matched controls
27900

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

XX3DW

NOMESCO Finland

Time consuming IT work

5.4

323.0

799

1924

130

Kela drug reimbursment

Malignant tumour

6.1

319.7

656

1334

WZC00

NOMESCO Finland

Treatment plan or consultation

4.3

312.2

1701

7428

HA1AA

NOMESCO Finland

X-ray mammography

5.9

308.8

654

1367

HAC20

NOMESCO Finland

Total mastectomy

8.4

308.4

437

601

A04AA01

ATC

ondansetron; systemic, rectal

9.0

307.7

851

1294

L03AA14

ATC

lipegfilgrastim; parenteral

24.7

307.7

469

226

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

10.5

307.7

407

447

JN4AD

NOMESCO Finland

Body CT examination

6.6

307.7

822

1653

WF049

NOMESCO Finland

Radiotherapy of metastasis

10.6

307.7

397

430

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

10.3

307.7

622

757

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

20.2

307.7

479

284

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

18.7

307.7

690

482

XW000

NOMESCO Finland

Bone marrow biopsy

10.1

307.7

469

545

WW500

NOMESCO Finland

Blood transfusion

19.1

307.7

691

473

D70.82

ICD-10 Finland

Drug-induced neutropenia

+∞

307.7

2790

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

21.1

307.7

905

622

A03FA01

ATC

metoclopramide; systemic, rectal

15.8

307.7

2056

4206

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

9.1

307.7

435

556

115

Kela drug reimbursment

Breast cancer

8.5

307.7

907

1504

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

29.3

307.7

325

125

A49.9

ICD-10 Finland

Bacterial infection, unspecified

16.4

307.7

1420

1657

L03AA13

ATC

pegfilgrastim; parenteral

24.8

307.7

1010

623

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

27.1

307.7

266

108

H02AB02

ATC

dexamethasone; systemic

20.9

307.7

1727

2009

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

20.4

307.7

286

155

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

9.5

307.7

443

543

JN4BD

NOMESCO Finland

Extensive body CT

8.7

307.7

999

1689

Z51.5

ICD-10 Finland

Palliative care

7.3

307.7

659

1136

N02AA05

ATC

oxycodone; systemic

5.6

307.7

1120

2983

D70.89

ICD-10 Finland

Neutropenic splenomegaly

29.3

307.7

304

116

A04AD12

ATC

aprepitant; systemic

17.9

307.7

395

255

R50.9

ICD-10 Finland

Fever, unspecified

8.1

307.7

1220

2452

A04AA55

ATC

palonosetron, combinations; systemic

11.2

307.7

507

543

L03AA02

ATC

filgrastim; parenteral

20.2

307.7

594

368

A04AA02

ATC

granisetron; systemic, transdermal

16.7

307.7

1057

981

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

13.9

307.7

613

554

ZX120

NOMESCO Finland

Intravenous

7.9

307.7

848

1467

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

20.8

307.7

294

157

TPX10

NOMESCO Finland

Implantation of vascular injection port

10.5

301.2

353

381

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

6.2

297.7

591

1160

L02BG04

ATC

letrozole; oral

6.2

296.9

590

1159

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

6.6

284.6

520

939

J01MA12

ATC

levofloxacin; systemic

4.3

281.8

1022

3296

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

6.5

269.4

497

904

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

23.8

260.6

189

L02BA01

ATC

tamoxifen; oral

7.4

260.2

409

629

GD1AA

NOMESCO Finland

Thorax X-ray examination

4.0

255.4

1905

9839

D69.5

ICD-10 Finland

Secondary thrombocytopenia

82.7

252.5

134

A41.9

ICD-10 Finland

Sepsis, unspecified

9.1

251.1

327

403

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

26.1

236.3

165

JN6AD

NOMESCO Finland

CT of torso and neck

13.7

235.7

226

179

ZX112

NOMESCO Finland

Subcutaneous

11.1

235.4

259

254

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

15.8

234.3

206

140

L01BC06

ATC

capecitabine; oral

7.4

230.9

362

553

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

7.5

230.3

354

529

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

6.0

227.2

449

867

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

13.6

218.2

209

165

PJA12

NOMESCO Finland

Sentinel node biopsy

4.7

207.2

570

1459

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

6.0

198.9

381

711

WF003

NOMESCO Finland

Adjuvant radiotherapy

7.1

188.0

302

471

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

3.1

185.0

1422

7023

ZX070

NOMESCO Finland

Intensity modified radiotherapy

10.7

183.2

205

WZC30

NOMESCO Finland

Teaching

3.5

178.1

811

2934

C83.1

ICD-10 Finland

Mantle cell lymphoma

52.4

176.2

101

ZX080

NOMESCO Finland

Image guided radiotherapy

8.3

171.8

235

305

X76

ICPC

Malignant neoplasm breast female

8.8

166.2

217

266

B01AB10

ATC

tinzaparin; parenteral

3.9

165.0

568

1699

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

12.0

159.7

164

144

WW300

NOMESCO Finland

Transfer of autologic stem cells

30.0

156.9

104

NK6AN

NOMESCO Finland

Total body bone isotope imaging

7.6

155.7

230

326

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

6.9

155.5

251

392

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.3

153.9

746

2777

M04AA01

ATC

allopurinol; systemic

3.6

150.3

592

1931

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

4.8

149.4

368

851

JN4CD

NOMESCO Finland

Very extensive body CT

6.1

147.7

272

485

1CD02, ,

NOMESCO Finland

12.9

143.7

141

115

L02BG06

ATC

exemestane; oral

9.1

143.6

180

209

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

4.8

143.2

349

799

L01CA04

ATC

vinorelbine; systemic

14.3

142.3

131

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

16.8

140.3

118

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

7.7

137.9

199

274

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

9.5

136.6

166

185

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

9.1

135.8

170

197

C50.99

ICD-10 Finland

Breast, unspecified

6.2

134.9

242

420

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

11.4

132.8

141

130

YNB10

NOMESCO Finland

Collection of stem cells for transplant

62.4

131.5

D64.9

ICD-10 Finland

Anaemia, unspecified

3.7

131.4

492

1543

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

8.3

129.8

176

225

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

7.2

128.1

196

288

L01CB01

ATC

etoposide; systemic

19.7

127.1

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

9.0

126.0

159

186

128

Kela drug reimbursment

Cancers of female genital organs

8.2

125.4

172

223

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

8.9

121.4

155

184

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

10.5

119.9

134

133

192

Kela drug reimbursment

Fulvestrant

20.4

118.8

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

5.4

118.2

249

501

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

6.4

117.7

203

338

PJA10

NOMESCO Finland

Exploration of lymph nodes

10.6

116.1

129

127

B01AB05

ATC

enoxaparin; parenteral

2.5

116.0

1201

6490

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.6

115.7

907

4297

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

5.7

115.6

225

421

L02BA03

ATC

fulvestrant; parenteral

15.8

114.0

UGC12

NOMESCO Finland

Flexible bronchoscopy

3.8

113.9

388

1136

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.1

113.9

584

2209

M05BX04

ATC

denosumab; parenteral

4.1

113.7

341

912

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

24.9

113.3

TGC00

NOMESCO Finland

Bronchial lavation

6.5

112.2

189

307

WF004

NOMESCO Finland

Palliative radiotherapy

7.6

110.7

161

223

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

8.1

110.2

152

198

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

5.8

109.2

208

381

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

3.8

106.1

362

1059

TPH04

NOMESCO Finland

Cathetrisation of vein

2.6

104.0

841

4012

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

9.6

103.7

124

135

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

6.3

103.0

180

303

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

4.6

102.9

257

596

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

8.4

101.6

135

168

A79

ICPC

Malignancy NOS

8.6

101.0

132

161

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

9.5

101.0

121

132

TQW20

NOMESCO Finland

Tatoe

9.5

101.0

121

132

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

16.1

100.3

ZX108

NOMESCO Finland

Inhalation

15.0

100.1

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

6.2

98.9

174

295

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

6.0

98.5

181

320

J01MA14

ATC

moxifloxacin; systemic

3.3

98.3

417

1402

A02BC02

ATC

pantoprazole; systemic

2.6

97.0

2188

16176

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

7.6

95.7

139

192

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

22.4

95.2

HAB40

NOMESCO Finland

Wedge excision of mammary gland

3.8

94.1

308

873

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

4.1

93.4

272

709

9680/3-C77.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph node, NOS

27.5

91.0

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

6.0

89.8

164

288

C50

ICD-10 Finland

Malignant neoplasm of breast

5.6

87.9

173

326

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.4

87.4

355

1158

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

8.9

86.4

109

127

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

7.3

83.7

125

178

Z51.0

ICD-10 Finland

Radiotherapy session

8.0

83.1

115

150

1501

Kela drug reimbursment

Palbociclib

13.3

82.9

H02AB06

ATC

prednisolone; systemic

2.1

82.3

1545

10242

C82.1

ICD-10 Finland

Follicular lymphoma grade II

14.2

82.0

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

11.2

81.8

Z31.5

ICD-10 Finland

Genetic counselling

3.9

80.9

254

697

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

3.8

79.2

255

712

ZX121

NOMESCO Finland

Central venous catheter

17.5

79.2

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

9.9

78.3

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

6.6

78.3

129

204

FM1FN

NOMESCO Finland

Heart function isotope examination

13.6

77.7

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

4.7

77.5

188

424

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

25.0

76.6

ZX090

NOMESCO Finland

Other technic of radiotherapy

5.0

76.3

171

361

N05AH02

ATC

clozapine; systemic

7.2

76.0

115

166

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

7.9

75.9

105

137

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

10.5

75.0

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.3

74.6

756

3903

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

8.3

74.5

123

WB133

NOMESCO Finland

Very demanding adjuvant cytostatic therapy

21.1

74.4

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

5.5

73.9

148

283

ED1AA

NOMESCO Finland

Mandibular X-ray examination

13.3

73.5

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

11.8

73.3

WX302

NOMESCO Finland

Thoracal epidural anesthesy

3.6

72.2

256

762

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

5.5

72.2

142

267

394

Kela drug reimbursment

Palbociclib

12.6

71.1

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

10.1

69.5

C83.39

ICD-10 Finland

Diffuse non-Hodgkin's large cell lymphoma UNS

28.1

69.4

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

8.9

69.1

101

WF002

NOMESCO Finland

Radical radiotherapy

3.5

68.9

250

755

ZZQ00

NOMESCO Finland

Free microvascular graft of skin

12.7

68.5

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.8

68.3

381

1482

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

14.1

67.4

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

4.7

67.3

163

367

TPX15

NOMESCO Finland

Removal of vascular injection port

15.0

66.6

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

6.1

66.4

117

198

N05AH03

ATC

olanzapine; systemic

3.3

66.4

264

845

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

4.9

66.3

149

315

A06AH03

ATC

naloxegol; oral

6.7

66.1

106

163

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

15.2

65.7

C81.1

ICD-10 Finland

Nodular sclerosis classical Hodgkin lymphoma

20.3

65.3

TGD00

NOMESCO Finland

Needle biopsy of lung

13.2

64.0

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

6.2

63.5

110

183

B03XA02

ATC

darbepoetin alfa; parenteral

5.3

63.0

130

255

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

9.5

62.9

C03CA01

ATC

furosemide; systemic

2.1

62.6

890

5187

L01XE33

ATC

[U] palbociclib

15.7

62.4

C81.9

ICD-10 Finland

Hodgkin lymphoma, unspecified

22.3

62.4

1XC02, ,

NOMESCO Finland

10.2

61.2

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.7

61.2

361

1442

Z80.3

ICD-10 Finland

Family history of malignant neoplasm of breast

5.6

61.0

119

222

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.6

60.8

385

1593

N05BA06

ATC

lorazepam; systemic, sublingual

3.4

60.0

227

703

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

16.2

59.9

B99

ICD-10 Finland

Other and unspecified infectious diseases

5.8

59.6

111

198

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

3.3

59.5

240

774

A41.8

ICD-10 Finland

Other specified sepsis

5.8

59.2

110

196

AA1BD

NOMESCO Finland

Extensive CT of head and brain

4.7

58.7

141

315

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

11.8

57.7

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

4.6

57.6

141

320

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

8.4

57.5

B00.2

ICD-10 Finland

Herpesviral gingivostomatitis and pharyngotonsillitis

16.8

57.4

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

7.7

57.4

108

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

5.8

57.0

106

189

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

5.9

56.4

102

177

9680/3-C77.8

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions

23.1

56.4

L02BG03

ATC

anastrozole; oral

5.4

56.4

113

216

1XC03, ,

NOMESCO Finland

15.0

56.3

HA1DG

NOMESCO Finland

Very extensive MRI examination of mammary gland with high intensity magnet

7.5

56.0

111

HA1CG

NOMESCO Finland

Extensive MRI examination of mammary gland with high intensity magnet

5.6

55.8

108

200

TPH07

NOMESCO Finland

Cathetrisation of artery

2.5

55.6

403

1775

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

7.7

55.3

104

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.4

55.2

423

1911

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

6.2

55.2

157

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

9.0

55.0

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

3.2

54.7

226

739

EP1AE

NOMESCO Finland

Neck ultrasound examination

3.1

54.6

252

879

WX408

NOMESCO Finland

General anesthesy, balanced

2.0

54.2

843

5024

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

8.3

54.0

ZXE10

NOMESCO Finland

More than one and less than three hours

1.9

53.9

1131

7438

JN3AD

NOMESCO Finland

Abdominal CT examination

2.4

53.6

413

1869

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.8

53.4

1562

11375

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

7.0

53.1

121

GD1AD

NOMESCO Finland

Thorax CT examination

3.0

52.7

248

874

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

4.1

52.7

148

373

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

3.7

52.5

173

489

I97.2

ICD-10 Finland

Postmastectomy lymphoedema syndrome

11.2

51.1

R50.8

ICD-10 Finland

Other specified fever

12.4

50.5

N05CF01

ATC

zopiclone; oral

1.9

49.8

995

6401

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

4.7

49.7

116

253

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.6

49.7

316

1305

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.5

49.5

357

1565

ZZF00

NOMESCO Finland

Graft of adipose tissue

7.7

49.3

C82.2

ICD-10 Finland

Follicular lymphoma grade III, unspecified

16.9

47.9

N02AA01

ATC

morphine; systemic, rectal

5.7

47.9

162

JAL30

NOMESCO Finland

Omentectomy

6.2

47.8

135

J05AB11

ATC

valaciclovir; oral

2.2

47.6

496

2539

WX402

NOMESCO Finland

General anaesthesia

2.0

46.9

692

4019

PJW99

NOMESCO Finland

Other operation on lymphatic system

11.0

46.9

WW409

NOMESCO Finland

Other aferesis

18.7

46.6

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

5.1

46.4

200

3AA13, ,

NOMESCO Finland

17.5

46.3

J01DB01

ATC

cefalexin; oral

2.2

46.1

2369

20169

163

Kela drug reimbursment

Abiraterone and enzalutamide

9.2

46.1

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

6.5

45.2

116

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.2

45.0

410

1985

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

4.7

45.0

105

229

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.8

44.7

1239

8715

C82.9

ICD-10 Finland

Follicular lymphoma, unspecified

18.2

44.7

L01EF01

ATC

palbociclib; oral

12.0

44.6

L02BB04

ATC

enzalutamide; oral

9.5

44.5

EE1AA

NOMESCO Finland

X-ray of upper jaw or palate

15.2

44.3

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

5.4

43.8

165

127

Kela drug reimbursment

Transplant complication

5.5

43.7

158

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

6.7

43.4

105

ZX095

NOMESCO Finland

Combined chemoradiotherapy

8.5

43.4

C50.82

ICD-10 Finland

Overall malignant tumor of the mammary gland, lobular tumor

7.4

43.3

8461/3-C56.9

ICD-O-3

High grade serous carcinoma of ovary

11.7

43.0

C50.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of breast

13.0

42.6

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

5.6

42.6

151

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.4

42.4

325

1459

KFC00

NOMESCO Finland

Unilateral orchiectomy

11.4

42.3

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

3.9

42.0

128

342

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

6.4

42.0

112

D40.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Testis

12.6

41.8

N02BE01

ATC

paracetamol; systemic, rectal

2.5

41.4

2550

22596

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

5.1

41.0

175

R18

ICD-10 Finland

Ascites

4.6

41.0

218

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

6.4

40.7

109

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

2.4

40.4

290

1263

ZXE30

NOMESCO Finland

More than five and less than seven hours

3.0

40.2

181

621

JAL00

NOMESCO Finland

Biopsy of peritoneum

9.9

40.1

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

4.9

40.1

186

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

4.5

40.1

226

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.8

40.1

722

4443

NK6AQ

NOMESCO Finland

Whole body bone SPET with low dose CT

13.3

40.0

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

6.3

40.0

111

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.7

39.6

200

HAE05

NOMESCO Finland

Reconstruction of breast using soft tissue and prosthesis

8.4

39.0

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

5.4

38.9

149

ZXE20

NOMESCO Finland

More than three and less than five hours

2.1

38.7

439

2308

212

Kela drug reimbursment

Gout

5.0

38.3

170

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

4.4

38.2

222

HAE99

NOMESCO Finland

Other reconstruction of breast

6.6

37.9

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

4.0

37.4

109

282

L01BC59

ATC

trifluridine, combinations; systemic

14.3

37.4

A06AD11

ATC

lactulose; oral

2.1

37.3

430

2272

ZXE00

NOMESCO Finland

One hour or less

1.7

36.9

1120

7954

R11

ICD-10 Finland

Nausea and vomiting

2.4

36.9

281

1256

A07AA09

ATC

vancomycin; oral

5.3

36.7

142

C50.89

ICD-10 Finland

Overall malignant tumor of the mammary gland, other or undeterminated histology

7.9

36.6

WB402

NOMESCO Finland

Demanding antibody therapy of primary tumour

8.5

36.5

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

3.0

36.4

166

573

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

5.6

36.2

126

SPAT1255

SPAT

Intravenous administration of medicine

2.5

36.0

241

1015

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

5.5

35.9

127

ZZR10

NOMESCO Finland

Flap of skin and muscle

6.1

35.8

103

L04AA06

ATC

mycophenolic acid; systemic

4.5

34.9

200

R59.9

ICD-10 Finland

Enlarged lymph nodes, unspecified

6.2

34.9

XX1AD

NOMESCO Finland

Other CT-examination

7.1

34.8

JAH00

NOMESCO Finland

Laparotomy

3.6

34.5

115

327

WVC10

NOMESCO Finland

Subcutaneous infusion of drugs

9.4

34.5

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

7.0

34.4

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.7

34.2

844

5644

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

4.3

34.0

217

SPAT1109

SPAT

Analgesia with portable analgesic pump

9.2

33.9

9673/3-C42.1

ICD-O-3

Mantle cell lymphoma of bone marrow

177.2

33.8

ZXD05

NOMESCO Finland

Urgent procedure

1.7

33.7

846

5679

XX1XN

NOMESCO Finland

Other isotope examination

5.9

33.5

103

HAD30

NOMESCO Finland

Reduction mammoplasty with transposition of areola

3.0

33.2

149

510

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

7.4

33.1

J94.8

ICD-10 Finland

Other specified pleural conditions

5.0

32.9

145

HAC15

NOMESCO Finland

Subcutaneous mastectomy with excision of mamilla

6.7

32.8

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

6.5

32.4

J01MA02

ATC

ciprofloxacin; systemic

1.6

32.2

1082

7810

ZXE40

NOMESCO Finland

More than seven and less than nine hours

3.9

32.1

253

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

6.6

31.9

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

11.5

31.8

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

31.8

855

5831

PJD45

NOMESCO Finland

Excision of inguinal lymph nodes

8.3

31.2

F20.9

ICD-10 Finland

Schizophrenia, unspecified

4.0

31.2

236

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

11.1

31.1

NK6BQ

NOMESCO Finland

Whole body extensive bone SPET with low dose CT

7.8

31.1

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

3.4

31.0

113

341

C20

ICD-10 Finland

Malignant neoplasm of rectum

7.2

31.0

A07AA02

ATC

nystatin; oral

2.5

30.9

201

834

C92.0

ICD-10 Finland

Acute myeloblastic leukaemia [AML]

10.4

30.7

A40.8

ICD-10 Finland

Other streptococcal sepsis

6.1

30.6

N05AD01

ATC

haloperidol; systemic

3.5

30.3

107

316

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

7.1

30.1

L02BX03

ATC

abiraterone; oral

8.4

30.0

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

5.6

29.8

101

C50.80

ICD-10 Finland

Overall malignant tumor of the mammary gland, no histological veryfication

9.6

29.7

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

3.3

29.6

115

361

H02AB09

ATC

hydrocortisone; systemic

3.6

29.0

286

L02AE03

ATC

goserelin; implant

5.2

29.0

118

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

8.9

28.9

Z2446

NOMESCO Finland

Social worker

2.4

28.9

206

892

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

5.0

28.7

123

R06AE07

ATC

cetirizine; oral

1.6

28.6

1231

9343

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

4.4

28.6

167

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

5.4

28.5

105

NK6CT

NOMESCO Finland

Bone biopsy with CT guidance

11.2

28.5

C56

ICD-10 Finland

Malignant neoplasm of ovary

6.9

28.4

L02AE02

ATC

leuprorelin; implant, parenteral

2.8

28.4

142

516

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

10.1

28.3

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.4

28.2

211

933

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

3.1

28.0

119

394

JN5JR

NOMESCO Finland

Extensive PET-CT of upper body metabolism (eyebrows to thighs)

39.4

28.0

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

3.1

28.0

118

389

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

4.1

28.0

187

Z3231

NOMESCO Finland

Registered nurse

1.6

27.9

763

5191

TJA10

NOMESCO Finland

Laparocentesis

10.8

27.8

HA1TE

NOMESCO Finland

Supplementary or limited ultrasound examination of mammary glands

5.4

27.6

101

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

5.7

27.4

HAB99

NOMESCO Finland

Other partial excision of mammary gland

3.2

27.3

108

343

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

3.8

27.2

222

A46

ICD-10 Finland

Erysipelas

1.9

27.2

414

2386

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.2

27.1

253

1226

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.7

26.8

146

555

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

26.6

1150

8694

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

8.2

26.5

352

Kela drug reimbursment

Abiraterone and enzalutamide

7.9

26.4

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.8

26.3

136

503

YJ1BD

NOMESCO Finland

Extensive CT examination of abdomen for dose design of radiotherapy

29.5

26.3

HA3AT

NOMESCO Finland

Pucture of mammary gland cyst with ultrasound examination

6.3

26.2

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

5.3

26.1

C83.80

ICD-10 Finland

B-cell lymphoma in marginal zone

9.8

25.9

YNB00

NOMESCO Finland

Excision of bone marrow for transplantation

40.5

25.8

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.8

25.8

464

2812

ZZQ10

NOMESCO Finland

Free microvascular graft of skin and muscle

8.6

25.8

ZX131

NOMESCO Finland

Intrathecal

263.0

25.7

3AA02, ,

NOMESCO Finland

94.3

25.7

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

8.7

25.4

M87.1

ICD-10 Finland

Osteonecrosis due to drugs

8.7

25.4

R84

ICPC

Malignant neoplasm bronchus/lung

9.5

25.3

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

4.1

25.2

175

C50.9

ICD-10 Finland

Malignant neoplasm: Breast, unspecified

6.8

25.1

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

3.4

25.1

274

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

4.1

25.0

176

ZY010

NOMESCO Finland

Hospital outpatient

2.6

25.0

154

622

B02.9

ICD-10 Finland

Zoster without complication

2.2

24.9

215

1009

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.2

24.9

214

1003

QX3AT

NOMESCO Finland

Ultrasound guided biopsy of subcutaneous tissue

6.4

24.8

8500/3-C50.2

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast

5.2

24.8

100

XW3AT

NOMESCO Finland

Biopsy of other superficial organ with ultrasound guidance

7.1

24.6

D38.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Mediastinum

9.4

24.4

SPAT1088

SPAT

Blood transfusion

8.3

24.4

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

6.6

24.3

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

8.9

24.2

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

2.0

24.0

291

1552

188

Kela drug reimbursment

Psychosis requiring demanding treatment

5.1

24.0

WPA13

NOMESCO Finland

Palliative consultation

9.1

23.9

WNF00

NOMESCO Finland

Infection source and contact determination

9.1

23.9

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.3

23.8

182

812

J05AB01

ATC

aciclovir; systemic

1.6

23.7

627

4208

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.9

23.5

115

413

WW200

NOMESCO Finland

Immunization

3.2

23.5

311

KBV15

NOMESCO Finland

Cystoscopic change of ureteral stent

7.3

23.3

WC125

NOMESCO Finland

Demanding cytostatic therapy of local tumor recidive

8.9

23.3

L04AD02

ATC

tacrolimus; systemic

5.4

23.3

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

6.4

23.1

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

23.1

469

2935

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

7.4

22.9

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

7.2

22.9

WZC15, ,

NOMESCO Finland

6.2

22.8

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.3

22.7

177

796

8500/3-C50.1

ICD-O-3

Infiltrating duct carcinoma, NOS, of central portion of breast

7.8

22.5

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.5

22.3

147

613

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

4.7

22.2

110

C83.00

ICD-10 Finland

Lymphocytic lymphoma

21.6

22.1

N04AA02

ATC

biperiden; systemic

3.7

22.0

198

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.6

21.8

128

505

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

6.4

21.8

ZX100

NOMESCO Finland

Oral

4.1

21.6

146

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

21.6

323

1846

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

5.8

21.5

JFF10

NOMESCO Finland

Loop enterostomy

6.4

21.4

E0000UV, ,

ATC

1.5

21.3

1103

8541

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

4.4

21.3

122

JAH01

NOMESCO Finland

Laparoscopy

2.5

21.3

140

584

D80.8

ICD-10 Finland

Other immunodeficiencies with predominantly antibody defects

50.4

21.1

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

3.2

21.0

274

5BA08, ,

NOMESCO Finland

6.5

20.9

N02AX02

ATC

tramadol; systemic, rectal

1.5

20.8

1168

9177

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.8

20.7

106

390

R4110

NOMESCO Finland

Physiotherapy

1.5

20.7

761

5486

C50.92

ICD-10 Finland

Malignant tumor in another specified localization in lobular gland, lobular tumor

6.4

20.5

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

4.2

20.5

130

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

4.1

20.4

139

JAL20

NOMESCO Finland

Excision or destruction of lesion of peritoneum

6.7

20.4

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

3.1

20.2

291

B72

ICPC

Hodgkin Lymphoma

32.8

20.2

KA1AE

NOMESCO Finland

Kidney ultrasound examination

3.1

20.1

287

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

3.2

20.0

261

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

3.3

20.0

236

B01AB04

ATC

dalteparin; parenteral

2.3

19.9

160

730

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

19.8

407

2548

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

3.7

19.6

166

ZYC01

NOMESCO Finland

Remote contact by phone

2.2

19.6

175

833

KH1FT

NOMESCO Finland

Exchange of urinary catheter with radiological guidance

6.9

19.5

ZZQ70

NOMESCO Finland

Free microvascular graft of lymph nodes

40.4

19.5

TQB05

NOMESCO Finland

Puncture of skin of trunk

4.5

19.4

106

1506

Kela drug reimbursment

The combination of trifluridine and tipiracil

14.7

19.4

3018

Kela drug reimbursment

The combination of trifluridine and tipiracil

14.7

19.4

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

14.7

19.4

GD6AD

NOMESCO Finland

CT of chest and neck

8.4

19.3

N05BA04

ATC

oxazepam; oral

1.5

19.3

694

4968

HA2AT

NOMESCO Finland

Cytology of mammary gland with ultrasound guidance

7.0

19.1

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.4

19.0

136

590

UJF32

NOMESCO Finland

Coloscopy

1.5

18.9

710

5125

HAD99

NOMESCO Finland

Other plastic operation on breast

5.5

18.8

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

8.1

18.8

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

4.9

18.7

GEA00

NOMESCO Finland

Mediastinoscopy

7.7

18.7

SPAT1245

SPAT

Provision of support and information to patient’s family members

2.5

18.7

114

459

I89.0

ICD-10 Finland

Lymphoedema, not elsewhere classified

5.2

18.6

SPAT1269

SPAT

Other puncture and/or drainage

6.1

18.6

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

4.1

18.5

127

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

18.5

1906

16627

JFB00

NOMESCO Finland

Partial resection of small intestine

3.7

18.3

160

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

3.0

18.3

265

N63

ICD-10 Finland

Unspecified lump in breast

2.0

18.2

192

973

C56.00

ICD-10 Finland

Malignant tumor of the ovary without histology

5.6

18.2

3030

Kela drug reimbursment

Abemaciclib

19.5

18.2

1515, ,

Kela drug reimbursment

19.5

18.2

N05AF05

ATC

zuclopenthixol; systemic

4.9

18.0

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

4.0

17.9

126

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.7

17.9

389

2468

XX2RW, ,

NOMESCO Finland

4.1

17.8

122

QBE20

NOMESCO Finland

Excision and repair of scar or web of skin of trunk

4.3

17.8

105

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

7.3

17.8

390

Kela drug reimbursment

Ibrutinib

20.2

17.7

WE300

NOMESCO Finland

Profylactive therapy of malignancy with biomoidiers

67.0

17.7

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

2.0

17.7

196

1012

L04AX01

ATC

azathioprine; systemic

2.3

17.5

128

561

D43.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, supratentorial

5.9

17.4

N95.1

ICD-10 Finland

Menopausal and female climacteric states

0.4

17.4

2117

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

7.1

17.4

L01EF03

ATC

abemaciclib; oral

17.0

17.4

PJ1AN

NOMESCO Finland

Lymphsystem isotope imaging

21.0

17.3

XW1AT

NOMESCO Finland

Biopsy from other organ close to skin with ultrasound quidance

5.2

17.2

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.3

17.2

129

571

RS220, ,

NOMESCO Finland

3.9

17.2

130

LAF11

NOMESCO Finland

Laparoscopic bilateral salpingo-oophorectomy

2.1

17.1

163

795

C50.20

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication

5.5

17.1

A03

ICPC

Fever

1.6

17.0

409

2658

D70.80

ICD-10 Finland

Agranulocytic angina

50.3

17.0

PG1BD

NOMESCO Finland

Extensive CT angiography of tissue graft, e.g. assessment of TRAN graft

50.3

17.0

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

3.3

17.0

198

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

2.7

16.9

344

HAE00

NOMESCO Finland

Reconstruction of breast using prosthesis

6.1

16.8

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

4.5

16.8

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.9

16.6

200

1063

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

3.4

16.6

181

WW402

NOMESCO Finland

Leucoferesis

27.7

16.5

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.1

16.4

169

849

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

4.1

16.4

112

X21

ICPC

Breast sympt/compl female other

3.0

16.3

245

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

3.8

16.2

131

J20.5

ICD-10 Finland

Acute bronchitis due to respiratory syncytial virus

7.1

16.1

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.8

16.1

296

Z42.1

ICD-10 Finland

Follow-up care involving plastic surgery of breast

5.3

16.1

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

4.3

16.0

N05AX12

ATC

aripiprazole; systemic

2.5

15.9

101

415

D39.10

ICD-10 Finland

Tumor of uncertain or unknown nature in the ovary without histology

2.7

15.9

304

D75

ICPC

Malignant neoplasm colon/rectum

4.6

15.9

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.0

15.9

168

853

RD211, ,

NOMESCO Finland

2.2

15.8

132

611

SPAT1254

SPAT

Administration of medicine

1.6

15.8

360

2307

C62.12

ICD-10 Finland

Malignant tumor of the descending testicle, embryonic carsinoma, teratocarcinoma or coriocarsinoma

60.4

15.8

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

15.8

925

7229

9680/3-C71.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of brain, NOS

33.6

15.7

C50.00

ICD-10 Finland

Malignant tumor of nipple and areola, no histological veryfication

5.0

15.7

WPA15

NOMESCO Finland

Palliative care consultation with the patient and loved ones

7.2

15.7

N05AA01

ATC

chlorpromazine; systemic, rectal

3.8

15.7

125

AAA10

NOMESCO Finland

Biopsy through craniotomy

85.6

15.6

HA6BA

NOMESCO Finland

Breast tomosynthesis specimen

3.7

15.5

135

C50.10

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, no histological veryfication

6.5

15.4

C77.3

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes

7.0

15.3

JN5KR

NOMESCO Finland

Very extensive PET-CT of upper body metabolism (eyebrows to thighs)

7.0

15.3

C50.52

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, lobular tumor

5.9

15.2

A28

ICPC

Limited function/disability NOS

1.6

15.2

416

2786

N03AX16

ATC

[U] pregabalin

1.5

15.2

623

4549

A05AA02

ATC

ursodeoxycholic acid; oral

3.3

15.2

171

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.1

15.1

142

689

ZXH04

NOMESCO Finland

Procedure performed in other inpatient unit

6.1

15.1

N06AX16

ATC

venlafaxine; oral

1.6

15.1

379

2488

HWD00

NOMESCO Finland

Reoperation for deep haemorrhage in surgery of mammary gland

4.7

14.9

WC105

NOMESCO Finland

Simple cytostatic therapy of local tumor recidive

6.5

14.9

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

15.1

14.9

D70

ICD-10 Finland

Agranulocytosis

57.0

14.8

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

3.3

14.8

174

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

5.5

14.8

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.3

14.8

110

486

N17.8

ICD-10 Finland

Other acute renal failure

3.9

14.8

112

B37.08

ICD-10 Finland

Other candidal stomatitis

4.3

14.8

AAG00

NOMESCO Finland

Stereotactic intracranial biopsy

16.6

14.8

A49.8

ICD-10 Finland

Other bacterial infections of unspecified site

4.4

14.7

L01BB05

ATC

fludarabine; systemic

21.1

14.6

WVA20

NOMESCO Finland

Medicine administration

2.7

14.6

306

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.6

14.6

263

4176

B00.19

ICD-10 Finland

Other vesicular dermatitis caused by the herper simplex virus

5.0

14.5

LAF16

NOMESCO Finland

Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer

5.0

14.5

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

3.0

14.4

213

K83.1

ICD-10 Finland

Obstruction of bile duct

3.5

14.3

138

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.2

14.3

117

538

LAF10

NOMESCO Finland

Bilateral salpingo-oophorectomy

2.3

14.3

103

449

N05AL05

ATC

amisulpride; oral

27.3

14.3

PJD63

NOMESCO Finland

Laparoscopic dissection of aortic lymph nodes

6.2

14.2

JDB10

NOMESCO Finland

Percutaneous gastrostomy

3.8

14.1

111

P01AB01

ATC

metronidazole; oral, rectal

1.4

14.1

1053

8529

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

3.3

14.1

164

ZX050

NOMESCO Finland

Stereotactic radiotherapy

4.3

14.1

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.6

14.1

336

2176

JKE18

NOMESCO Finland

Endoscopic internal drainage of bile duct

4.0

14.1

C82.01

ICD-10 Finland

Follicular nodular lymphoma, grade I

12.0

14.1

C50.39

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, other or undeterminated histology

6.7

14.0

A04AA03

ATC

tropisetron; systemic

6.7

14.0

E83.50

ICD-10 Finland

Hypercalcemia

3.5

14.0

140

L04AD01

ATC

ciclosporin; systemic

3.0

13.9

212

F20.39

ICD-10 Finland

Undifferentiated schizophrenia UNS

6.0

13.9

D72.8

ICD-10 Finland

Other specified disorders of white blood cells

4.4

13.8

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

4.9

13.8

C50.29

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology

4.9

13.8

N05AA02

ATC

levomepromazine; systemic

2.3

13.7

109

495

R4190

NOMESCO Finland

Nutritional therapy

2.3

13.7

104

463

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

5.7

13.7

UGC18

NOMESCO Finland

Flexible bronchoscopy with biopsy of lung

5.7

13.7

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.1

13.6

136

676

N05AN01

ATC

lithium; oral

2.7

13.6

265

SPAT1263

SPAT

Sampling

1.4

13.6

1047

8509

WF099

NOMESCO Finland

Other radiotherapy

4.8

13.5

1512

Kela drug reimbursment

Ibrutinib

16.3

13.4

K12.10

ICD-10 Finland

Stomatitis NOS

5.2

13.4

C81.7

ICD-10 Finland

Other classical Hodgkin lymphoma

25.9

13.4

A02BC01

ATC

omeprazole; systemic

1.4

13.3

684

5192

WB303

NOMESCO Finland

Simple adjuvant therapy of malignancy with biomodifiers

11.5

13.3

QBA00

NOMESCO Finland

Puncture of skin of trunk

6.3

13.3

SPAT1153

SPAT

Removal of sutures

1.4

13.2

836

6576

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

13.1

408

2805

QB2S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in chest

4.8

13.1

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

4.8

13.1

C50.22

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor

4.5

13.1

XX2AT

NOMESCO Finland

Other injection with ultrasound examination

3.2

13.0

157

F20.10

ICD-10 Finland

Raise schizophrenia continuously

6.2

12.9

E83.4

ICD-10 Finland

Disorders of magnesium metabolism

13.0

12.9

NE1DG

NOMESCO Finland

Pelvic, hip and femur very extensive MRI examination with high intensity magnet

5.0

12.9

XX9CD

NOMESCO Finland

Very extensive complementary CT

22.6

12.9

WX702

NOMESCO Finland

Supraglottic ventilation device

1.9

12.9

163

881

8041/3-C34.9

ICD-O-3

Small cell carcinoma, NOS, of lung, NOS

11.6

12.8

NEA10

NOMESCO Finland

Exploration of soft tissue of pelvis, percutaneous

5.4

12.8

C50.59

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology

5.8

12.7

C10AA07

ATC

rosuvastatin; oral

0.7

12.6

501

6738

TGA30

NOMESCO Finland

Thoracocentesis

4.8

12.6

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

2.9

12.6

203

XX9AQ

NOMESCO Finland

Supplementary SPECT-CT or additional scan

10.1

12.5

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.7

12.5

260

C81.2

ICD-10 Finland

Mixed cellularity classical Hodgkin lymphoma

20.1

12.4

HWH99

NOMESCO Finland

Other reoperation in surgery of mammary gland

5.6

12.4

AA1AD

NOMESCO Finland

CT of head and brain

1.4

12.3

673

5152

G62.0

ICD-10 Finland

Drug-induced polyneuropathy

9.0

12.2

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

5.1

12.2

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

4.9

12.2

HA1BA

NOMESCO Finland

Extensive X-ray mammography

4.5

12.1

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

6.0

12.1

P72

ICPC

Schizophrenia

2.9

12.1

202

B34.9

ICD-10 Finland

Viral infection, unspecified

2.6

12.1

282

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.4

12.1

361

J01FF01

ATC

clindamycin; systemic

1.4

12.1

689

5314

A02BC05

ATC

esomeprazole; systemic

1.3

12.0

1055

8703

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

2.8

12.0

208

1CD01, ,

NOMESCO Finland

9.3

12.0

WPB10

NOMESCO Finland

Making a convalescent care decision

5.7

11.9

HAD40

NOMESCO Finland

Mastopexy

5.0

11.9

HA1HA

NOMESCO Finland

Tomosynthesis mammography

4.9

11.9

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.7

11.9

242

1505

L01AA02

ATC

chlorambucil; oral

11.7

11.8

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

3.5

11.8

116

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

3.2

11.7

147

9663/3-C77.9

ICD-O-3

Hodgkin lymphoma, nodular sclerosis, NOS, of lymph node, NOS

30.1

11.6

Z51.3

ICD-10 Finland

Blood transfusion (without reported diagnosis)

19.0

11.6

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.9

11.5

135

712

8500/3-C50.8

ICD-O-3

Infiltrating duct carcinoma, NOS, of overlapping lesion of breast

5.7

11.5

SPAT1301

SPAT

No procedures

1.4

11.4

763

6026

C83.71

ICD-10 Finland

Burkitt's tumour

120.5

11.4

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

3.3

11.4

129

HA1SA

NOMESCO Finland

Expansion mammography

5.4

11.3

D37.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified

5.4

11.3

8500/3-C50.5

ICD-O-3

Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast

4.2

11.3

L02AB02

ATC

medroxyprogesterone; systemic

4.2

11.3

369

Kela drug reimbursment

Regorafenib

9.6

11.2

ZX114

NOMESCO Finland

Intramuscular

3.1

11.2

151

TAB00

NOMESCO Finland

Lumbar puncture

2.0

11.2

120

614

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.8

11.1

200

C83.89

ICD-10 Finland

Other types of diffuse non-Hodgkin's lymphoma

25.1

11.1

L01XE27

ATC

[U] ibrutinib

20.1

11.1

J70.0

ICD-10 Finland

Acute pulmonary manifestations due to radiation

11.2

11.0

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

8.6

11.0

TK800

NOMESCO Finland

Hemodialysis

2.6

11.0

236

YN1BD

NOMESCO Finland

Extensive CT examination of extremities for dose design of radiotherapy

13.9

11.0

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.7

10.9

196

1177

C10AX09

ATC

ezetimibe; oral

0.6

10.9

179

2930

D61.1

ICD-10 Finland

Drug-induced aplastic anaemia

43.5

10.9

A10AB05

ATC

insulin aspart; parenteral

1.7

10.9

183

1079

JN3DG

NOMESCO Finland

Very extensive MRI examination with high intensity magnet

5.4

10.9

A29

ICPC

General symptom/complaint other

1.5

10.8

311

2099

OAB43, ,

SPAT

0.7

10.8

300

4345

I88.9

ICD-10 Finland

Nonspecific lymphadenitis, unspecified

4.9

10.7

9680/3-C42.1

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of bone marrow

28.1

10.7

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.8

10.7

158

897

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.6

10.6

284

1887

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

5.3

10.6

WVA30, ,

SPAT

1.9

10.5

138

756

J70.2

ICD-10 Finland

Acute drug-induced interstitial lung disorders

10.1

10.5

C34.86

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary microcellular carcinoma

10.1

10.5

HAD60

NOMESCO Finland

Replacement of prosthetic implant in breast

9.2

10.5

L01BC53

ATC

tegafur, combinations; systemic

14.2

10.5

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

3.6

10.5

WX730

NOMESCO Finland

Conventional respirator

3.1

10.4

136

9085/3-C62.9

ICD-O-3

Mixed germ cell tumor of testis, NOS

110.4

10.4

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

3.7

10.4

L01AA01

ATC

cyclophosphamide; systemic

5.4

10.4

GAA96

NOMESCO Finland

Other open or percutaneous drainage of pleural cavity

5.4

10.4

Z73.8

ICD-10 Finland

Other problems related to life-management difficulty

4.2

10.3

159

Kela drug reimbursment

Pazopanib

12.1

10.3

S18

ICPC

Laceration/cut

1.3

10.3

1171

9952

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

2.6

10.3

220

N03AX14

ATC

levetiracetam; systemic

2.3

10.3

342

ZYY98

NOMESCO Finland

Missed treatment contact, no notification given by patient

8.2

10.3

QBJ00

NOMESCO Finland

Liposuction in trunk

4.3

10.3

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.7

10.3

211

1314

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.7

10.3

206

1275

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

4.9

10.3

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.3

10.2

343

B03BA03

ATC

hydroxocobalamin; parenteral

1.9

10.2

131

713

C50.50

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, no histological veryfication

7.5

10.2

191

Kela drug reimbursment

Erlotinib

13.1

10.1

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

7.9

10.1

N05AH04

ATC

quetiapine; oral

1.4

10.0

402

2903

J02AC03

ATC

voriconazole; systemic

10.1

10.0

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

2.8

10.0

178

KBV00

NOMESCO Finland

Insertion of stent into ureter

4.2

9.9

X77

ICPC

Malignant neopl genital female other

7.6

9.9

Y77

ICPC

Malignant neoplasm prostate

2.3

9.9

304

C81.0

ICD-10 Finland

Nodular lymphocyte predominant Hodgkin lymphoma

16.8

9.9

Z43.3

ICD-10 Finland

Attention to colostomy

12.2

9.8

R06.0

ICD-10 Finland

Dyspnoea

1.4

9.8

661

5210

C54.21

ICD-10 Finland

Leiomyosarcoma and myometrium

20.1

9.8

L01EL01

ATC

ibrutinib; oral

20.1

9.8

C84.59

ICD-10 Finland

Other and unspecified T-cell lymphomas

20.1

9.8

SPAT1262

SPAT

Handing over of treatment supplies

1.4

9.8

418

3054

SPAT1229

SPAT

Assessment of need for aid

1.7

9.7

187

1145

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

2.0

9.7

107

553

121

Kela drug reimbursment

Severe hypofunction of sexual glands

2.5

9.7

245

9680/3-C16.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of stomach, NOS

55.2

9.6

156

Kela drug reimbursment

Lapatinib

55.2

9.6

NF3AA

NOMESCO Finland

Femur X-ray examination

2.5

9.6

228

GDC00

NOMESCO Finland

Lobectomy of lung

4.8

9.5

ZXF99

NOMESCO Finland

Other r3eason to interrupt procedure

4.6

9.5

8500/3-C50.3

ICD-O-3

Infiltrating duct carcinoma, NOS, of lower-inner quadrant of breast

4.0

9.5

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

3.8

9.5

8070/3-C34.3

ICD-O-3

Squamous cell carcinoma, NOS, of lower lobe, lung

7.1

9.5

C85.7

ICD-10 Finland

Other specified types of non-Hodgkin lymphoma

30.1

9.4

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

4.0

9.3

K59.09

ICD-10 Finland

Constipation, unspecified

1.7

9.3

160

951

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

4.7

9.3

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

2.9

9.2

141

HA1BG

NOMESCO Finland

MRI examination of mammary gland with high intensity magnet

3.4

9.2

TPH05

NOMESCO Finland

Open cannulation of peripheral vein

3.9

9.1

J02AC01

ATC

fluconazole; systemic

1.3

9.1

1008

8501

C82.00

ICD-10 Finland

Follicular nodular non-Hodgkin's lymphoma, ungraded

11.5

9.1

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

2.5

9.0

223

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

3.0

9.0

132

X19

ICPC

Breast lump/mass female

2.7

9.0

182

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

3.2

9.0

106

WC115

NOMESCO Finland

Cytostatic therapy of local tumor recidive with multiple drugs

15.6

9.0

JEA00

NOMESCO Finland

Appendectomy

1.8

9.0

142

823

WB111

NOMESCO Finland

Multiple neoadjuvant cytostatic therapy

9.1

9.0

9673/3-C77.9

ICD-O-3

Mantle cell lymphoma of lymph node, NOS

36.8

9.0

TQW99

NOMESCO Finland

Other minor procedure on skin

1.8

9.0

127

713

N05AF03

ATC

chlorprothixene; systemic

2.3

9.0

273

C90.0

ICD-10 Finland

Multiple myeloma

3.1

9.0

122

A98

ICPC

Health maint/preventive medicine

0.7

8.9

2512

25993

M25.5

ICD-10 Finland

Pain in joint

0.7

8.9

520

6631

C62.11

ICD-10 Finland

Malignant tumor of the descending testicle, seminoma

24.1

8.9

Z94.0

ICD-10 Finland

Kidney transplant status

3.2

8.9

107

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.3

8.9

306

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

3.9

8.9

C34.16

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary microcellular carcinoma

8.0

8.8

WB223

NOMESCO Finland

Demanding adjuvant hormone therapy of malignancy

4.9

8.8

L02BB03

ATC

bicalutamide; oral

2.4

8.8

238

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.0

8.8

433

HAD20

NOMESCO Finland

Liposuction of breast

8.6

8.8

QXB05

NOMESCO Finland

Skin wound assessment, unspecified location

4.0

8.8

C78.1

ICD-10 Finland

Secondary malignant neoplasm of mediastinum

10.7

8.8

A07EC01

ATC

sulfasalazine; oral, rectal

1.6

8.8

199

1272

E000006, ,

ATC

1.7

8.8

164

998

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

8.8

313

2209

R17

ICD-10 Finland

Hyperbilirubinaemia, with or without jaundice, not elsewhere classified

2.9

8.7

140

Z51.88

ICD-10 Finland

Other specified medical care

2.5

8.7

209

R60.0

ICD-10 Finland

Localized oedema

1.5

8.7

292

2034

ECB20

NOMESCO Finland

Oral alveoplasty

3.1

8.7

119

E87.6

ICD-10 Finland

Hypokalaemia

2.0

8.7

442

ZXC40

NOMESCO Finland

Use of ultrasound

3.9

8.7

YX9CD

NOMESCO Finland

Other very extensive CT eamination for dose design of radiotherapy

14.1

8.7

SPAT1290

SPAT

Preparation of deceased person

14.1

8.7

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

4.4

8.6

F20.5

ICD-10 Finland

Residual schizophrenia

4.4

8.6

D48.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage

2.9

8.6

136

N05AX08

ATC

risperidone; systemic

1.7

8.6

171

1058

JN5AN

NOMESCO Finland

Total body isotope imaging

16.3

8.5

YJ1AD

NOMESCO Finland

CT examination of abdomen for dose design of radiotherapy

9.0

8.5

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

3.4

8.5

WF001

NOMESCO Finland

Preoperative radiotherapy

3.4

8.5

C84.51

ICD-10 Finland

Other and unspecified T-cell lymphomas

27.6

8.5

C96.9

ICD-10 Finland

Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified

20.1

8.5

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

2.8

8.4

154

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.2

8.4

300

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

8.4

171

1063

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

8.4

948

7991

9663/3-C77.8

ICD-O-3

Hodgkin lymphoma, nodular sclerosis, NOS, of lymph nodes of multiple regions

90.3

8.4

I82.88

ICD-10 Finland

Embolism and thrombosis of other specified veins

2.5

8.4

201

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

2.9

8.4

127

LCA06

NOMESCO Finland

Biopsy of endometrium

1.5

8.4

296

2084

B73

ICPC

Leukaemia

12.8

8.4

JK3BT

NOMESCO Finland

Catherisation of bile duct with X-ray guidance

4.9

8.4

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

2.7

8.3

155

C16.9

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

4.7

8.3

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.0

8.3

477

C34.39

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung other or unspecified histology

8.5

8.3

T80.8

ICD-10 Finland

Other complications following infusion, transfusion and therapeutic injection

10.8

8.3

NFR30

NOMESCO Finland

Extended excision of soft tissue tumour of hip or thigh

10.8

8.3

C56.73

ICD-10 Finland

Endomeroid epithelial carcinoma of the ovary

9.5

8.3

N18.8

ICD-10 Finland

Other chronic renal failure

2.3

8.3

258

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.2

8.2

303

A07EA06

ATC

budesonide; oral, local oral

2.0

8.2

444

-50

ICPC

Medication/prescr/renewal

1.9

8.2

103

557

E61.2

ICD-10 Finland

Magnesium deficiency

14.5

8.2

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

2.7

8.2

151

K50.1

ICD-10 Finland

Crohn disease of large intestine

3.0

8.2

113

E86

ICD-10 Finland

Volume depletion

2.3

8.1

247

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1185

3924

4.51

321.57

9.1

3.3

0.78

0.82

mmol/l

20.60

1164

3682

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1155

3777

4.51

318.18

2.7

1.8

—

(3021440) Promyelocytes/100 leukocytes in Blood

790

1949

5.26

309.38

5.7

4.2

0.27

0.11

6.73

601

588

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

465

573

9.54

307.65

2.3

1.6

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

411

11.55

307.65

2.3

1.6

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

415

476

10.07

307.65

7.9

5.0

452.23

672.33

iu/ml

0.33

(4035726) Immunohistochemistry procedure

903

2235

5.50

307.65

1.7

1.4

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

462

561

9.67

307.65

2.4

1.6

—

(3017181) Myelocytes/100 leukocytes in Blood

876

2043

5.79

307.65

5.6

4.1

1.41

0.92

5.58

688

682

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

350

319

12.40

307.65

2.0

1.6

—

(3023368) Bacteria identified in Blood by Culture

1858

6264

6.89

307.65

8.6

4.3

—

(3004809) Band form neutrophils/100 leukocytes in Blood

348

372

10.55

298.94

4.1

3.4

2.33

1.34

3.53

330

333

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2263

12550

5.25

289.26

19.3

6.3

9.92

11.20

umol/l

5.83

2222

11925

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

291

254

12.67

286.62

2.1

1.7

—

(3045142) Bone marrow Pathology biopsy report

295

276

11.83

277.59

1.8

1.3

—

(3002179) Metamyelocytes/100 leukocytes in Blood

734

1875

4.96

272.77

5.4

3.9

0.97

0.66

3.65

550

596

(3042111) Morphology [Interpretation] in Bone marrow Narrative

343

410

9.40

270.29

2.2

1.6

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

239

171

15.19

264.65

1.5

1.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

230

155

16.08

263.10

2.7

1.9

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

871

2610

4.40

262.98

2.5

1.8

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

681

1690

5.01

261.26

2.3

1.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

867

2610

4.37

259.82

2.3

1.7

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

2344

13903

5.29

259.65

34.9

9.1

3.19

4.07

e9/l

89.79

2249

12135

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

491

928

6.21

255.34

2.6

2.0

1.72

1.92

ug/l

0.15

471

830

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

873

2680

4.29

254.16

8.8

4.3

257.42

246.67

u/l

1.00

856

2536

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

178

25.28

251.59

2.4

1.7

—

(3011412) CD3 cells [#/volume] in Blood

252

215

12.79

251.30

3.1

2.0

0.97

1.15

e9/l

1.59

241

197

(3025159) Blasts/100 leukocytes in Blood

701

1841

4.75

249.95

5.9

4.2

0.13

0.41

0.61

512

489

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

312

374

9.27

244.79

3.5

2.6

20525.75

1981.19

u/ml

0.56

(1175426) CD3 cells/100 lymphocytes in Blood

224

167

14.50

242.08

2.6

1.9

75.85

71.80

1.86

219

157

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

291

328

9.79

239.29

1.9

1.5

—

(21494814) CD8 cells/100 lymphocytes in Specimen

183

20.76

238.51

2.3

1.7

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

318

428

8.26

226.65

2.0

1.5

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

219

179

13.19

223.93

2.1

1.7

—

(3018418) pH of Serum or Plasma

1499

7159

3.36

215.54

10.1

4.1

7.40

0.41

581

1352

(40768795) Lymph node Pathology biopsy report

240

10.85

214.92

1.5

1.2

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1983

11264

3.63

212.95

14.1

6.4

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

791

2561

3.92

209.24

5.9

4.1

27.24

23.29

ug/l

0.19

657

2069

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

174

107

17.28

208.17

4.8

3.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

265

323

8.96

204.50

2.0

1.5

—

(3019069) Monocytes/100 leukocytes in Blood

1963

11265

3.51

203.20

11.8

6.4

9.73

8.59

19.82

1911

10540

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2042

12020

3.61

202.42

13.8

6.9

1.21

1.22

mmol/l

1.31

1555

10260

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

278

371

8.21

199.04

2.0

1.5

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

663

1972

4.10

196.71

10.3

3.8

1.23

mmol/l

0.28

642

1726

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

177

127

14.81

195.02

2.1

1.7

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

176

127

14.72

193.29

2.1

1.7

—

(3002030) Lymphocytes/100 leukocytes in Blood

1972

11547

3.41

193.08

11.6

6.2

27.40

28.01

1.15

1915

10835

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1906

10953

3.34

192.34

11.8

6.1

1.21

mmol/l

0.36

1846

9977

(3006504) Eosinophils/100 leukocytes in Blood

1929

11202

3.34

190.39

11.4

6.1

2.27

2.84

18.17

1878

10467

(3022096) Basophils/100 leukocytes in Blood

1888

10874

3.28

188.00

11.3

6.1

0.65

0.68

1.66

1837

10141

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

181

150

12.83

183.10

2.0

1.6

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

206

211

10.46

180.97

1.4

1.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

546

1581

4.05

166.12

1.5

1.4

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

189

194

10.38

165.61

1.7

1.6

—

(3018010) Neutrophils/100 leukocytes in Blood

1892

11401

3.05

164.22

10.8

6.0

54.83

57.10

7.61

1837

10684

(3006315) Basophils [#/volume] in Blood

1949

11975

3.08

162.52

11.0

5.9

0.03

0.04

e9/l

35.29

1796

10341

(3024561) Albumin [Mass/volume] in Serum or Plasma

1767

10311

2.95

161.84

9.2

4.9

32.78

35.56

g/l

64.58

1704

9615

(3001604) Monocytes [#/volume] in Blood

1944

11945

3.07

161.73

11.0

5.9

0.56

0.58

e9/l

0.55

1793

10320

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

257

402

6.94

159.00

2.4

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

257

402

6.94

159.00

2.4

1.5

—

(3013115) Eosinophils [#/volume] in Blood

1979

12398

3.05

156.56

12.0

6.1

0.13

0.19

e9/l

58.25

1834

10853

(3019198) Lymphocytes [#/volume] in Blood

1965

12264

3.04

156.51

11.2

5.9

1.55

1.95

e9/l

10.35

1831

10841

(3005719) IgG [Mass/volume] in Serum or Plasma

575

1818

3.72

153.25

4.9

2.8

9.12

10.57

g/l

7.32

552

1658

(3027945) Reticulocytes/100 erythrocytes in Blood

707

2582

3.33

150.10

4.4

2.6

1.78

1.81

0.32

669

2287

(3000850) Epithelial cells [#/volume] in Urine

1062

4933

2.86

146.82

3.4

2.6

6.38

5.75

e6/l

0.70

1003

4416

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

676

2487

3.27

140.90

6.4

3.3

—

(3000012) Reticulocyte production index

217

322

7.22

140.71

2.5

2.2

—

(3022217) INR in Platelet poor plasma by Coagulation assay

1782

10907

2.75

140.71

12.1

14.6

1.17

1.25

inr

6.12

784

3168

(3017143) Hepatitis C virus Ab [Presence] in Serum

672

2472

3.26

140.00

1.7

1.6

—

(3023520) Reticulocytes [#/volume] in Blood

577

1933

3.50

139.82

4.1

2.6

68.02

70.92

e9/l

0.99

484

1467

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2513

18673

4.48

139.26

24.0

7.7

88.03

78.10

u/l

13.28

2484

17607

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

195

264

7.87

137.13

2.3

1.5

—

(3002582) Erythrocytes [#/volume] in Urine

1320

7052

2.65

136.07

4.2

3.2

126.82

76.44

e6/l

0.43

1140

5401

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

40.20

134.68

2.1

2.3

1.72

1.45

mg/l

0.19

(3015377) Calcium [Moles/volume] in Serum or Plasma

1462

8267

2.61

133.16

9.0

3.4

2.34

2.36

mmol/l

6.07

1397

7272

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

182

241

8.01

130.36

2.3

1.6

—

(40761536) Microorganisms panel - Urine sediment

564

1976

3.32

126.23

5.2

4.0

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

259

511

5.48

125.85

1.6

1.4

—

(3028026) IgM [Mass/volume] in Serum or Plasma

465

1445

3.66

125.58

2.7

1.9

1.09

1.42

g/l

2.79

444

1316

(3026782) Osmolality of Urine

974

4666

2.67

122.65

3.5

2.9

503.83

533.30

mosm/kgh2o

4.35

907

4001

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

299

685

4.77

122.02

1.7

1.8

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

715

2977

2.88

117.58

1.7

1.6

—

(3030467) Casts [#/volume] in Urine by Automated count

1203

6514

2.49

115.61

3.9

3.1

0.45

0.41

e6/l

0.23

1034

4944

(3003458) Phosphate [Moles/volume] in Serum or Plasma

738

3159

2.82

114.88

8.6

6.0

1.03

1.04

mmol/l

0.50

723

2928

(3042936) Bacteria identified in Isolate by Culture

772

3400

2.76

113.59

2.1

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

283

661

4.65

112.54

1.7

1.3

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

180

278

6.85

112.14

2.0

1.5

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

180

278

6.85

112.14

2.0

1.5

—

(36304419) Bacteria [Presence] in Urine

1172

6348

2.46

111.60

3.8

3.0

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1747

11306

2.46

111.24

4.3

2.6

—

(3021589) Normoblasts [#/volume] in Blood

1670

10598

2.43

111.05

26.0

9.5

0.00

e9/l

1.26

1470

8662

(3031040) Bacteria [#/volume] in Urine by Automated count

2170

15556

2.78

110.73

5.8

4.5

688.60

1791.68

e6/l

0.92

208

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

14.47

107.77

1.4

1.3

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

152

209

7.63

105.18

2.5

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

152

209

7.63

105.18

2.5

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

152

209

7.63

105.18

2.5

1.5

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

412

1321

3.49

105.07

1.8

1.5

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

1998

13930

2.53

104.99

8.9

4.7

6.67

6.68

mmol/l

0.12

1945

13058

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

225

460

5.23

104.69

1.5

1.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

246

551

4.80

102.78

1.6

1.5

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

269

652

4.46

101.84

1.3

1.2

—

(3018095) Leukocytes [#/volume] in Urine

1382

8296

2.32

101.23

4.8

3.7

97.20

102.06

e6/l

0.07

1166

5838

(3008757) Leukocyte morphology finding [Identifier] in Blood

163

254

6.75

100.58

4.8

3.9

—

(3042631) Mycobacterium sp identified in Specimen

183

326

5.94

98.84

2.2

2.9

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

129

158

8.51

98.34

3.9

2.0

421.76

719.25

e6/l

4.05

118

153

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

296

806

3.99

95.76

2.6

2.7

—

(3012501) Base excess in Blood by calculation

228

514

4.74

94.37

3.9

4.7

2.34

2.64

mmol/l

0.83

172

354

(3013290) Carbon dioxide [Partial pressure] in Blood

228

515

4.73

94.14

4.0

4.7

4.84

5.05

kpa

3.63

223

509

(3027315) Oxygen [Partial pressure] in Blood

228

518

4.70

93.46

4.0

4.7

8.60

8.54

kpa

0.17

223

511

(3018677) aPTT in Platelet poor plasma by Coagulation assay

758

3610

2.51

92.51

3.2

2.1

29.72

29.66

0.09

745

3504

(3044640) Blood type and Crossmatch panel - Blood

1280

7650

2.24

92.18

4.6

2.4

—

(40758558) Short blood count panel - Blood

1093

6158

2.27

90.49

25.4

6.7

—

(3029937) Albumin [Presence] in Urine by Test strip

1093

6160

2.27

90.40

5.5

4.1

0.00

estimate

1.28

575

2061

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1259

7521

2.23

90.23

3.5

2.6

51.74

69.91

u/l

1.04

1199

6928

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

197

414

5.04

88.58

1.6

1.4

106.21

123.09

u/ml

0.74

(3010421) pH of Blood

243

617

4.22

86.27

4.0

4.4

7.44

7.42

7.26

230

557

(3026008) Bacteria identified in Urine by Culture

1205

7240

2.17

83.27

3.4

3.1

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

719

3511

2.41

81.73

1.8

1.7

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

111

142

8.10

81.56

5.0

2.5

36.44

42.65

2.03

(40768793) Breast Pathology biopsy report

239

644

3.97

78.08

1.3

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

191

443

4.55

76.07

1.3

1.2

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

528

2313

2.58

75.24

2.4

2.2

0.20

0.21

g/l

5.51

505

2179

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

181

417

4.57

72.65

1.4

1.2

255.42

273.75

u/ml

0.33

125

255

(1616796) Gas panel - Central venous blood

199

501

4.20

71.22

3.8

3.9

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

366

1370

2.92

70.55

9.2

3.5

62.59

60.18

u/ml

0.08

354

1321

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

367

1390

2.89

69.17

5.8

7.6

24.83

24.88

mmol/l

0.09

362

1383

(40767503) Oxygen content in Capillary blood by calculation

194

495

4.14

68.15

2.7

2.6

14.74

16.16

3.75

258

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

152

320

4.97

68.01

1.2

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

8.72

65.91

1.5

1.3

—

(3025941) Bacteria identified in Stool by Culture

349

1324

2.87

65.41

1.5

1.2

—

(3020630) Protein [Mass/volume] in Serum or Plasma

453

1990

2.52

63.36

3.7

2.8

64.32

66.57

g/l

6.55

435

1815

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

103

8.27

62.47

1.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

220

652

3.58

62.31

1.4

1.2

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

647

3360

2.21

61.39

2.4

2.5

2.16

2.33

g/l

9.72

619

3115

(3036481) Cortisol [Moles/volume] in Serum or Plasma

480

2224

2.40

59.50

3.0

2.2

371.67

367.43

nmol/l

0.16

462

2035

(3020779) Urea [Moles/volume] in Serum or Plasma

458

2079

2.44

59.42

10.1

8.0

8.78

9.67

mmol/l

2.24

444

1990

(3004588) Protein electrophoresis panel - Serum or Plasma

394

1668

2.59

59.31

2.4

2.6

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

610

3150

2.20

58.37

2.5

2.6

25.28

23.02

2.40

563

2692

(3022948) Iron [Moles/volume] in Serum or Plasma

676

3642

2.13

58.00

2.5

13.09

13.24

umol/l

0.16

649

3397

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1189

7813

1.91

57.89

6.7

3.3

38.49

33.67

u/l

1.83

1141

7425

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

218

679

3.40

57.08

2.9

2.4

3.80

3.62

g/l

0.79

210

642

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

142

327

4.52

56.91

5.3

7.2

11.84

11.88

mg/l

0.04

134

303

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

149

6.49

56.88

3.7

2.0

561.13

496.35

e6/l

0.36

128

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1307

8914

1.88

56.17

4.3

3.6

23.77

99.96

ng/l

0.85

1077

6091

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

116

229

5.24

55.82

1.3

1.2

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1281

8726

1.87

54.86

5.4

3.9

—

(3041096) Erythrocytes [Presence] in Urine by Automated

974

6081

1.92

54.64

5.0

3.4

—

(3007853) Bacteria identified in Skin by Aerobe culture

544

2751

2.21

54.46

1.8

1.7

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

118

242

5.05

54.37

2.6

2.4

—

(1617658) Protocol used for examination of sentinel lymph nodes

111

219

5.24

53.45

1.0

1.1

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

128

290

4.58

52.33

2.9

1.8

21.76

23.47

ug/l

0.21

128

284

(3017354) Segmented neutrophils/100 leukocytes in Blood

113

232

5.03

51.99

3.4

48.80

57.02

2.78

199

(3008536) Aspergillus sp Ab [Presence] in Serum

11.45

51.84

3.1

1.5

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

126

6.51

48.70

3.2

1.5

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

126

6.51

48.70

3.2

1.5

—

(3021601) Nitrite [Presence] in Urine by Test strip

1557

11519

1.80

48.62

6.4

5.0

0.00

estimate

0.50

616

2131

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

142

6.07

47.68

4.0

2.0

0.19

0.21

e9/l

0.19

127

(3009261) Glucose [Presence] in Urine by Test strip

1566

11648

1.79

47.59

5.3

3.7

0.00

estimate

1.08

611

2058

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

174

527

3.45

47.49

5.4

3.6

247.44

832.87

u/ml

0.63

163

491

(3037467) Urinalysis macro (dipstick) panel - Urine

2027

16312

1.89

47.23

6.0

4.4

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

102

7.12

47.08

3.5

1.6

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

102

7.12

47.08

3.5

1.6

—

(3035350) Ketones [Presence] in Urine by Test strip

1548

11507

1.78

46.83

5.3

3.7

0.00

estimate

0.99

625

2255

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

103

7.05

46.67

3.5

1.6

—

(40765096) Chromosome analysis panel by Banding

7.71

46.34

1.2

1.1

—

(3033658) Prothrombin time (PT) actual/Normal

949

6147

1.82

45.59

6.7

3.8

89.55

91.30

1.48

932

5988

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

516

2737

2.09

44.89

5.4

2.7

12.97

8.08

umol/l

2.54

468

2385

(40768804) Tissue Pathology biopsy report

1386

10075

1.75

44.45

2.5

2.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

15.20

44.28

2.7

1.9

—

(3003694) ABO and Rh group [Type] in Blood

966

6360

1.79

43.50

1.7

1.4

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

415

2057

2.20

42.87

6.5

7.0

1.39

1.32

mmol/l

0.69

409

2014

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

7.22

42.41

1.6

2.2

737.50

33446.07

u/ml

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

906

5891

1.80

42.31

4.3

2.3

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

732

4467

1.87

42.01

6.0

3.1

2.47

2.45

mmol/l

3.44

682

3944

(3028626) Oxygen [Partial pressure] in Capillary blood

164

517

3.31

41.96

3.1

3.2

8.17

8.10

kpa

0.22

159

507

(3002256) Pathology report gross observation

567

3221

1.95

40.27

1.4

1.3

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

8.64

40.02

1.6

1.2

—

(3018405) Lactate [Moles/volume] in Arterial blood

216

821

2.77

39.76

4.4

3.8

1.53

1.37

mmol/l

0.87

208

808

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2160

24176

0.53

39.63

4.5

5.1

2.74

2.78

mmol/l

1.18

1958

22272

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

207

772

2.82

39.50

3.0

3.3

0.36

u/ml

0.00

128

445

(21494434) Karyotype in Bone marrow

225

4.48

39.39

1.4

1.2

—

(40768806) Pleura Pathology biopsy report

101

241

4.31

38.65

1.4

1.5

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

411

2110

2.11

38.55

4.6

3.7

5.64

5.84

kpa

4.34

400

2051

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

152

486

3.25

37.98

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

152

486

3.25

37.98

1.4

1.3

—

(3002032) Base excess in Venous blood by calculation

407

2104

2.09

37.41

4.7

3.7

2.14

1.96

mmol/l

0.41

346

1786

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

220

871

2.66

37.36

4.2

3.5

3332.79

1879.86

u/ml

0.18

195

738

(3016502) Oxygen saturation in Arterial blood

447

2395

2.03

37.27

8.7

8.2

95.67

95.69

0.02

432

2313

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2097

23580

0.55

36.33

4.2

4.5

1.45

1.49

mmol/l

4.45

1906

21705

(3021901) Oxygen saturation in Capillary blood

137

424

3.35

36.08

2.9

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

160

550

3.03

35.36

2.1

1.3

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2124

23751

0.56

34.77

4.2

4.5

4.67

4.71

mmol/l

1.07

1955

22002

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

244

1058

2.43

34.19

1.9

1.8

1.65

1.56

g/l

0.55

212

921

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

297

1406

2.24

33.98

2.3

1.6

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

300

1432

2.23

33.63

4.3

3.7

2.20

1.82

mmol/l

0.96

231

1092

(3009343) pH of Capillary blood

309

1494

2.20

33.56

4.3

3.7

7.43

7.41

2.50

190

(3000991) Gas panel - Venous blood

375

1954

2.06

33.53

8.2

8.5

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

10.40

33.36

1.5

1.6

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

189

734

2.69

33.29

2.7

2.1

87.81

91.20

1.05

183

704

(3015235) Bicarbonate [Moles/volume] in Capillary blood

165

603

2.85

32.64

3.0

3.2

24.40

25.02

mmol/l

0.99

159

593

(3027801) Oxygen [Partial pressure] in Arterial blood

473

2705

1.90

32.26

8.5

7.7

12.60

12.43

kpa

0.27

456

2582

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

473

2705

1.90

32.26

8.5

7.7

5.00

5.12

kpa

1.76

453

2584

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

308

1514

2.16

32.03

4.4

3.7

4.96

5.16

kpa

3.40

295

1447

(3003396) Base excess in Arterial blood by calculation

470

2692

1.90

31.88

8.5

7.7

1.75

1.12

mmol/l

3.37

376

2139

(3024471) HLA-A [Type]

6.91

31.83

1.0

—

(3000494) Fungus identified in Specimen by Culture

499

2924

1.86

31.49

1.9

1.4

—

(3020891) Body temperature

220

945

2.44

31.42

5.4

4.5

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

295

1443

2.17

31.03

9.6

7.6

24.74

24.63

mmol/l

0.18

285

1365

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

228

4.00

31.00

1.2

1.3

—

(3019060) Gas panel - Arterial blood

310

1547

2.13

30.98

6.8

5.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

121

382

3.27

30.86

1.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

223

981

2.38

30.19

3.3

1.9

—

(3026493) Urate [Moles/volume] in Serum or Plasma

899

6275

1.64

30.16

5.8

2.7

1870.35

4378.61

umol/l

2.04

837

5495

(3028433) Virus identified in Specimen by Culture

6.17

29.73

1.4

1.2

—

(3007164) IgA [Mass/volume] in Serum or Plasma

697

4571

1.70

29.67

2.2

1.5

2.12

2.43

g/l

4.24

535

2745

(3002173) Hemoglobin [Mass/volume] in Arterial blood

401

2231

1.93

29.54

9.3

8.7

111.59

121.56

g/l

18.09

391

2169

(3012441) Differential panel - Pleural fluid

237

3.85

29.38

1.4

1.5

—

(3003434) Protein [Mass/volume] in Pleural fluid

103

303

3.49

29.37

1.4

1.5

36.10

33.13

g/l

1.73

272

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

6.91

29.29

1.2

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

7.14

28.84

1.2

1.1

—

(3037756) Immunofixation for Serum or Plasma

143

518

2.86

28.74

1.7

1.8

—

(3023419) Bacteria identified in Sputum by Culture

118

384

3.16

28.63

2.3

2.7

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

936

6685

1.60

28.16

3.4

3.0

1493.65

1206.37

ng/l

0.99

847

5709

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

10.44

28.02

1.9

1.7

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

228

3.81

27.79

1.7

1.6

—

(3024932) HLA-DR beta [Type]

6.52

27.73

1.3

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

157

610

2.67

27.60

4.1

3.3

1.51

1.58

mg/l

0.47

148

558

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

298

3.41

27.26

1.4

1.5

0.28

0.31

nmol/l

0.27

221

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

146

4.53

26.89

1.3

1.2

—

(40758292) HTLV I+II Ab panel - Serum

9.01

26.84

1.4

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

6.92

26.74

1.5

1.1

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

841

5931

1.60

26.31

2.3

2.2

3.27

2.97

mg/l

2.54

761

5038

(3026250) Tacrolimus [Mass/volume] in Blood

5.45

26.19

41.3

31.9

7.62

7.54

ug/l

0.07

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

141

538

2.71

25.68

2.1

1.4

12.90

31.71

e6/l

0.81

123

406

(3001964) Herpes simplex virus Ag [Presence] in Specimen

6.22

25.36

1.8

1.4

—

(3006245) CD3-CD19+ cells/100 cells in Blood

6.03

25.13

3.3

2.0

11.32

9.36

0.25

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

140

539

2.68

25.06

2.1

1.4

254.59

1277.67

e6/l

1.15

128

432

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

6.14

25.01

1.6

1.2

20.83

9.89

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

757

5264

1.60

24.87

2.2

1.8

2.08

1.18

mg/l

4.88

599

4056

(3024354) Oxygen [Partial pressure] in Venous blood

316

1730

1.93

24.19

4.1

3.0

4.62

4.65

kpa

0.08

308

1676

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

107

4.93

23.91

1.9

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

107

4.93

23.91

1.9

1.4

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

114

406

2.88

23.65

1.2

1.3

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

151

621

2.51

23.63

1.9

1.3

742.96

516.02

mg/l

0.68

144

586

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

5.83

23.21

4.5

2.0

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

235

1176

2.09

23.13

3.9

2.8

0.19

0.28

e6/l

1.17

229

1146

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

194

901

2.24

23.07

2.4

1.8

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

136

4.33

22.76

1.9

1.4

—

(3044889) 12 lead EKG panel

1967

16984

1.54

22.62

5.0

3.8

—

(40768441) Liver Pathology biopsy report

186

3.78

22.44

1.4

1.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

200

3.67

22.42

1.2

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

134

4.32

22.30

1.9

1.4

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2564

23722

2.00

22.15

42.6

14.2

27.93

23.36

mg/l

11.19

2412

18747

(3000060) B lymphocytes [#/volume] in Blood

6.95

21.64

3.4

1.9

92.86

126.67

e6/l

0.31

(3025468) Yersinia sp identified in Specimen by Organism specific culture

314

3.03

21.24

2.5

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

314

3.03

21.24

2.5

1.4

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

206

1014

2.11

21.15

4.0

3.7

49.42

49.67

0.05

206

999

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2068

22775

0.64

21.12

3.9

4.0

1.37

1.29

mmol/l

4.83

1873

20795

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

321

3.00

21.05

2.5

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

316

3.01

21.01

2.5

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

323

2.98

20.82

2.5

1.4

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

201

3.55

20.77

1.3

493.47

347.89

u/l

0.81

195

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

326

2.95

20.49

2.5

1.4

—

(3044290) Cell count panel - Cerebral spinal fluid

125

503

2.55

20.49

2.0

1.4

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1997

22122

0.66

20.45

5.4

5.8

39.77

39.75

mmol/mol

0.04

1826

20447

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

6.73

20.41

1.4

—

(4281824) Cell count and differential, peritoneal fluid

286

3.07

20.17

1.3

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

127

523

2.50

19.84

4.4

2.0

377.73

3196.16

u/l

3.27

209

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

117

4.33

19.70

1.7

1.4

62.82

74.13

0.36

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

153

3.85

19.48

1.2

1.1

—

(3008295) Osmolality of Serum or Plasma

256

3.15

19.37

1.2

1.3

276.93

278.35

mosm/kgh2o

0.24

195

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

154

3.82

19.30

1.4

12.16

13.27

u/l

0.31

146

(3006184) Hemoglobin [Mass/volume] in Capillary blood

126

524

2.47

19.28

2.5

2.3

117.45

129.44

g/l

6.07

109

380

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

550

3744

1.58

19.08

3.8

2.9

2.83

2.67

e6/l

0.16

320

2034

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

4.94

18.98

1.4

1.5

64.33

60.11

0.27

(3015736) pH of Urine

1159

9222

1.44

18.70

4.6

3.4

5.70

5.82

0.34

630

(3010375) cycloSPORINE [Mass/volume] in Blood

110

4.33

18.53

36.9

27.0

134.29

115.61

ug/l

0.89

(3003181) Sodium [Moles/volume] in Urine

107

421

2.60

18.38

1.3

65.87

62.55

mmol/l

0.35

344

(40760888) Immunoglobulin light chains.free panel - Serum

132

576

2.36

18.17

3.4

4.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

134

593

2.32

17.87

1.3

1.2

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1249

10131

1.42

17.85

2.6

2.2

78.06

78.27

nmol/l

0.10

1181

9095

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

147

677

2.24

17.84

3.0

2.4

202.04

192.12

0.67

141

645

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

160

770

2.14

17.41

3.3

3.9

36.44

71.86

mg/l

1.05

110

629

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

5.67

17.27

1.3

1.2

106.40

96.40

ug/l

0.05

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

156

748

2.15

17.14

3.2

3.8

2.05

1.49

ratio

0.26

(3034860) Kappa light chains.free [Mass/volume] in Serum

159

769

2.13

17.08

3.3

3.9

47.16

60.90

mg/l

0.64

110

628

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

392

2.58

16.81

1.1

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

318

1947

1.71

16.63

5.1

2.5

57.02

65.92

ml/min/173m2

3.93

137

770

(3027273) Bicarbonate [Moles/volume] in Venous blood

204

1096

1.93

16.39

4.3

3.2

25.16

25.39

mmol/l

0.40

199

1065

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

239

3.02

16.36

4.1

2.7

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

245

2.99

16.28

1.6

1.4

34365.61

103384.21

e6/l

1.10

137

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

30.21

16.10

2.2

1.7

—

(3023199) Leukocytes [#/volume] in Pleural fluid

280

2.84

16.03

1.5

1.4

2466.16

1962.41

e6/l

0.32

196

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

690

5095

1.47

16.00

1.7

16275657.59

32986710.90

pmol/l

0.45

596

4226

(3035637) Corticotropin [Mass/volume] in Plasma

289

2.75

15.13

1.7

1.5

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

5.32

14.66

1.3

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

160

3.36

14.64

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

4.82

14.48

1.3

1.1

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

559

4032

1.48

14.41

3.6

2.7

1.31

1.09

e6/l

0.54

330

2310

(3003338) MCHC [Mass/volume]

1783

19821

0.72

14.38

50.2

18.4

331.06

332.08

g/l

5.50

1773

19699

(3036489) Thrombin time

169

894

1.95

14.22

2.8

2.0

21.64

21.49

0.12

154

785

(3035880) pH of Pleural fluid

120

3.71

14.16

1.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

107

476

2.30

14.15

1.4

1.7

—

(40757373) Influenza virus identified in Isolate

5.23

13.90

1.9

1.5

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

191

1064

1.85

13.73

3.4

2.5

0.67

0.65

0.58

191

1057

(3002385) Erythrocyte distribution width [Ratio]

2235

20489

1.46

13.66

46.6

16.9

15.22

15.03

1.13

2223

20132

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2174

23322

0.69

13.49

4.8

4.7

5.93

mmol/l

0.01

1996

21245

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

278

2.67

13.46

1.2

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

120

3.62

13.40

2.4

2.2

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

193

1089

1.83

13.32

3.5

2.5

1.23

1.19

0.27

193

1080

(3014148) Varicella zoster virus Ab [Titer] in Serum

247

2.75

13.16

1.2

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

113

3.67

13.02

1.9

1.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

113

3.67

13.02

1.9

1.7

—

(3023183) Ammonium ion [Moles/volume] in Plasma

110

513

2.19

13.01

2.4

3.0

33.93

34.59

umol/l

0.10

464

(3051651) Icteric interference index of Serum or Plasma

152

3.26

13.00

4.6

3.5

—

(3040151) Glucose [Moles/volume] in Capillary blood

249

2.73

12.96

15.1

6.1

7.92

7.29

mmol/l

0.43

209

(3036782) Glucose [Moles/volume] in Pleural fluid

218

2.84

12.71

1.3

1.4

5.90

6.46

mmol/l

0.79

203

(3009466) Valproate [Moles/volume] in Serum or Plasma

348

2.43

12.57

6.7

5.4

394.78

361.42

umol/l

1.23

302

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

101

462

2.23

12.53

3.2

3.1

—

(3046861) Legionella sp Ag [Presence] in Urine

24.41

12.45

1.1

1.0

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

139

725

1.97

12.21

1.6

0.01

9.17

iu/ml

0.50

132

(3019977) pH of Arterial blood

119

3.48

12.08

2.7

3.0

7.44

7.42

0.52

(40761535) Cells panel - Urine sediment

302

1985

1.58

11.83

4.4

3.5

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

135

705

1.96

11.83

1.5

1.1

—

(3019309) Folate [Moles/volume] in Red Blood Cells

570

4275

1.42

11.68

1.9

1.7

1432.67

1170.91

nmol/l

9.00

466

3206

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

22.98

11.56

1.8

1.0

—

(3052851) Hemolysis interference index of Serum or Plasma

136

718

1.94

11.55

4.2

3.3

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1192

10052

1.32

11.52

3.1

2.8

383.33

128.06

ug/l

18.00

1128

9279

(3014765) Yersinia sp identified in Stool by Organism specific culture

135

713

1.94

11.45

1.5

1.1

—

(3013512) EKG study

885

7158

1.35

11.35

4.2

3.8

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

385

2.27

11.27

1.2

1.4

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

2582

24601

1.66

11.24

38.7

16.2

139.05

139.72

mmol/l

32.96

2547

24005

(3009214) Lutropin [Units/volume] in Serum or Plasma

105

512

2.09

11.13

1.7

1.4

13.24

11.52

u/l

0.55

415

(42529406) Shigella sp [Presence] in Stool by Culture

135

721

1.92

11.09

1.5

1.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

331

2.36

11.08

1.4

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

163

2.98

10.99

1.5

1.6

3.47

6.10

u/l

1.34

139

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

9.23

10.99

1.0

—

(3021960) Folate [Moles/volume] in Serum or Plasma

704

5527

1.37

10.87

1.7

1.5

19.90

20.89

nmol/l

0.86

646

4685

(3013707) Erythrocyte sedimentation rate by Westergren method

1969

17901

1.34

10.80

6.3

4.2

18.83

12.26

mm/h

35.90

1862

16563

(3023323) Follitropin [Units/volume] in Serum or Plasma

167

963

1.78

10.75

1.6

1.4

34.37

31.92

iu/l

0.37

140

825

(3045788) Cell count panel - Pleural fluid

221

2.66

10.75

1.4

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

21.53

10.67

1.1

1.0

—

(3009871) Measles virus Ab [Titer] in Serum

3.86

10.65

1.7

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

146

3.05

10.50

2.5

1.7

—

(3052592) Norovirus Ag [Presence] in Stool

5.44

10.40

1.8

1.4

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

2583

24675

1.63

10.34

39.2

16.4

3.95

3.96

mmol/l

1.08

2547

24045

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

10.62

10.26

1.2

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

119

634

1.92

9.87

1.7

2.0

11.48

11.74

mg/l

0.04

114

583

(3013862) HLA-DP [Type]

16.75

9.87

1.0

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

327

2278

1.49

9.78

3.4

2.4

30.44

58.11

u/l

0.74

293

1971

(3022145) Colonoscopy Study observation

384

2769

1.45

9.62

1.4

1.3

—

(3017569) Oxygen content in Arterial blood

122

3.14

9.61

2.9

2.4

—

(3007566) Smooth muscle Ab [Titer] in Serum

123

669

1.88

9.59

1.3

1.2

112.73

86.96

titre

0.39

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

7.15

9.49

1.2

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

100

3.33

9.16

3.4

4.7

—

(21494755) Public health laboratory ask at order entry panel

105

1900

0.54

9.16

1.2

1.3

—

(3022313) Gas panel - Capillary blood

177

1090

1.67

9.03

5.2

3.9

—

(40760409) HLA-A [Type] by High resolution

15.63

9.02

1.0

—

(40760410) HLA-B [Type] by High resolution

15.63

9.02

1.0

—

(46236302) HLA-C [Type] by High resolution typing

15.63

9.02

1.0

—

(40763590) HLA-DQ beta [Type]

15.63

9.02

1.0

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

158

945

1.71

8.99

8.7

6.2

1.64

1.58

0.23

147

880

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

170

1040

1.68

8.90

1.7

1.9

40.96

38.46

u/l

0.68

156

922

(3017732) Neutrophils [#/volume] in Blood

248

1668

1.53

8.75

4.5

3.2

4.29

4.95

e9/l

0.57

209

1350

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

3.32

8.61

1.1

—

(3016038) Potassium [Moles/volume] in Urine

147

2.82

8.59

1.1

1.2

34.87

34.17

mmol/l

0.07

129

(3016018) Differential panel - Cerebral spinal fluid

266

2.32

8.58

2.2

1.4

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

3.63

8.55

1.0

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

115

1977

0.56

8.40

1.7

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

497

3836

1.36

8.31

1.5

1.4

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

176

2.58

8.00

2.1

1.5

1.41

4.45

ug/l

1.23

144

(3042733) HLA Ab [Presence] in Serum

3.59

7.85

5.8

4.7

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

4.06

7.80

1.5

1.3

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1713

15579

1.26

7.73

4.5

3.2

81.86

48.82

u/l

12.16

1618

14465

(3007930) Methemoglobin/Hemoglobin.total in Blood

152

939

1.65

7.69

8.9

6.2

0.87

0.89

0.18

141

875

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

137

827

1.69

7.58

3.4

2.6

1.50

1.10

g/l

0.32

119

724

(3033799) Differential panel - Peritoneal fluid

3.49

7.54

1.3

2.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

394

0.23

7.43

1.9

1.5

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

3.36

7.38

1.2

2.2

25625.00

27050.86

e6/l

0.01

(3024980) IgG subclass 4 [Mass/volume] in Serum

373

2.01

7.29

1.4

1.6

0.63

0.78

g/l

0.56

280

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

3.84

7.25

1.2

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

406

5221

0.74

7.15

4.5

4.3

21.16

21.27

0.05

217

2566

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

119

704

1.72

7.10

2.2

1.6

0.23

g/l

0.23

111

670

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

868

7358

1.26

7.09

2.9

2.1

186.04

211.69

u/l

0.28

823

6909

(3047181) Lactate [Moles/volume] in Blood

123

738

1.70

6.98

10.0

7.4

1.36

1.29

mmol/l

0.38

107

648

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

544

6694

0.77

6.96

1.7

1.6

1.47

1.38

mmol/l

1.15

439

5619

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

113

2.85

6.95

1.0

1.1

—

(4062490) Immunoglobulin typing, IgG

233

2.26

6.93

1.4

1.5

—

(3037121) Protein [Mass/volume] in Urine

136

841

1.65

6.89

6.0

3.3

0.41

0.29

g/l

0.21

340

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

13.80

6.89

1.1

1.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

221

1528

1.48

6.86

1.6

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

384

1.95

6.74

1.7

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

148

940

1.61

6.74

5.8

4.0

25.17

24.91

mmol/l

0.47

143

878

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

16.72

6.74

1.0

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

121

730

1.69

6.74

2.2

1.6

1.14

1.18

g/l

0.49

114

696

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

138

2.63

6.71

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

3.31

6.69

1.9

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

231

2.23

6.64

1.4

1.5

6.59

6.75

g/l

0.09

158

(3024139) IgG subclass 3 [Mass/volume] in Serum

231

2.23

6.64

1.4

1.5

0.41

0.37

g/l

0.23

159

(3028192) IgG subclass 2 [Mass/volume] in Serum

231

2.23

6.64

1.4

1.5

2.66

2.87

g/l

0.27

160

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

281

3786

0.71

6.62

2.6

3.1

0.87

0.73

ug/l

0.91

194

2560

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

394

1.93

6.60

1.2

1.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

12.26

6.58

1.1

1.0

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

133

830

1.63

6.52

2.6

2.3

280.89

751.12

ug/l

1.12

123

784

(3019150) Specific gravity of Urine by Refractometry

609

4993

1.28

6.47

5.5

4.1

1.02

kg/l

0.02

699

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

142

903

1.60

6.45

2.9

2.6

3.23

2.94

g/l

2.00

136

819

(3051611) Lipemic interference index of Serum or Plasma

254

2.15

6.42

4.6

3.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1321

0.54

6.41

1.6

1.4

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

2.91

6.31

1.0

1.1

1364.77

1593.39

miu/ml

0.44

(3006922) Hepatitis E virus Ab [Presence] in Serum

156

2.46

6.19

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

150

2.49

6.19

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

150

2.49

6.19

1.1

1.0

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

119

732

1.65

6.18

3.1

2.5

0.01

0.02

g/l

0.27

113

674

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

3.41

6.14

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

3.41

6.14

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

3.41

6.14

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

3.41

6.14

1.0

1.1

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2377

22705

1.32

6.13

37.3

13.2

81.69

80.45

ml/min/173m2

2.15

2200

18768

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

300

2.02

6.10

1.4

40.86

30.62

u/l

1.36

246

(3023487) Leukocytes [#/volume] in Peritoneal fluid

2.94

6.00

1.2

2.4

729.68

809.78

e6/l

0.12

(40768446) Kidney Pathology biopsy report

2.91

5.88

1.5

1.7

—

(1002224) Polysomnography panel

950

0.49

5.87

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

229

3128

0.71

5.83

3.9

4.6

31.16

32.69

1.28

166

2108

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

183

1272

1.47

5.57

12.2

10.9

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

145

963

1.53

5.50

2.8

2.6

3.62

3.65

g/l

0.08

139

878

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

145

963

1.53

5.50

2.8

2.6

7.57

7.38

g/l

0.60

139

877

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

145

963

1.53

5.50

2.8

2.6

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

117

2.58

5.46

1.9

6.3

—

56.68

—

(3035933) Granulocytes/100 leukocytes in Blood

3.29

5.30

4.7

1.5

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

9.12

5.28

1.5

1.1

—

(40768797) Stomach Pathology biopsy report

436

3514

1.29

5.23

1.3

1.2

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

3.06

5.22

1.0

1.5

14.01

13.99

g/l

0.00

(3017501) Neutrophils [#/volume] in Blood by Manual count

+∞

5.21

1.8

0.0

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

3.02

5.10

7.8

1.6

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.18

5.04

1.8

2.8

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.18

5.04

1.8

2.9

—

(3037522) Nuclear Ab [Titer] in Serum

411

3305

1.29

5.01

1.4

1.3

688.89

529.75

titre

0.77

718

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

135

2.39

4.97

1.2

1.1

1.12

1.04

ratio

0.53

(3044007) Cell count panel - Peritoneal fluid

3.04

4.94

1.2

2.1

—

(3020393) Adenovirus Ag [Presence] in Stool

6.02

4.91

1.3

1.5

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

7.17

4.65

3.7

4.2

—

(3004451) EKG impression Narrative

127

2.38

4.65

1.4

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

134

2.33

4.59

1.5

1.7

2.36

3.44

u/field

0.32

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

254

1.95

4.59

1.1

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

14.03

4.57

1.0

—

(3020876) Protein [Mass/time] in 24 hour Urine

269

1.91

4.54

3.0

2.4

1.40

1.39

g/24h

0.01

137

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

102

655

1.58

4.54

1.3

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

187

2.10

4.52

1.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

114

754

1.53

4.47

3.1

2.4

34.73

37.84

g/l

6.10

107

668

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

2.54

4.46

1.2

1.1

3060.00

466.48

ng/l

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

4.39

4.43

1.0

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

143

2.25

4.41

1.2

1.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

105

685

1.55

4.38

3.3

2.5

0.00

g/l

-0.00

629

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

224

1.98

4.35

1.2

1.1

—

(3010937) Rubella virus Ab [Presence] in Serum

7.52

4.35

1.0

—

(3045414) Leukocytes [Presence] in Urine

157

1114

1.43

4.35

2.3

1.9

—

(3020682) Albumin/Creatinine [Ratio] in Urine

659

7597

0.83

4.34

4.0

3.8

10.46

8.70

mg/mmol

0.52

395

4690

(3048879) Bone marrow aspiration report

2.89

4.33

2.2

1.6

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

162

1160

1.42

4.27

1.5

1.3

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

130

893

1.48

4.27

3.0

2.6

9.90

10.26

g/l

0.30

123

802

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

589

0.45

4.26

1.4

1.5

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

355

0.31

4.17

1.5

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.67

4.15

1.3

1.2

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

540

4576

1.22

4.13

3.5

3.6

351.37

609.91

ng/l

0.48

429

3501

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

5.90

4.12

4.1

9.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

4.08

3.90

2.2

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

4.08

3.90

2.2

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

4.08

3.90

2.2

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

7.29

3.86

2.6

1.3

—

(3047189) Immunofixation for 24 hour Urine

126

2.23

3.83

1.7

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

202

1530

1.35

3.82

3.6

3.3

4.42

4.46

pmol/l

0.11

181

1353

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

251

1965

1.30

3.77

2.2

2.4

7.18

7.14

ug/l

0.01

219

1753

(3024869) Neuronal Ab [Presence] in Serum

3.19

3.77

1.2

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

8.77

3.77

1.6

1.1

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

8.77

3.77

2.9

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

335

0.33

3.76

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

334

0.33

3.74

1.4

—

(21494890) Protein electrophoresis panel - 24 hour Urine

266

1.82

3.74

2.0

2.2

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

333

0.33

3.72

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

333

0.33

3.72

1.4

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.84

3.69

3.3

4.4

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

118

823

1.45

3.63

1.7

1.6

612.00

314.36

titre

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

4.01

3.59

1.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

191

1.95

3.58

1.2

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

880

0.59

3.53

1.9

1.7

7.59

4.01

mg/l

0.75

644

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2130

22118

0.84

3.50

5.3

4.9

3.28

2.12

mu/l

0.44

1979

20249

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

132

2.13

3.45

1.6

1.5

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

121

1675

0.71

3.39

1.2

1.3

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

2.58

3.38

1.6

1.4

361.94

77.49

nmol/24h

0.49

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

343

1.68

3.37

1.1

116.52

116.47

0.00

310

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

581

1.51

3.34

1.2

1.3

144.45

215.98

miu/ml

1.11

264

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

270

1.75

3.29

1.3

1.8

—

1370.00

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

3.03

3.25

2.7

3.2

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

170

1.95

3.24

1.1

577.67

266.91

mg/l

0.66

148

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.87

3.19

2.1

1.1

—

(40761511) CBC panel - Blood by Automated count

2527

24666

1.26

3.17

34.0

13.4

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

110

779

1.43

3.16

2.1

1.8

—

(4146454) Self-monitoring of blood glucose

290

0.34

3.15

1.5

2.7

—

(3039000) Anion gap in Blood

517

1.52

3.13

14.3

8.9

10.67

11.32

mmol/l

0.88

460

(3018572) Chloride [Moles/volume] in Blood

518

1.52

3.10

14.3

8.9

105.92

105.17

mmol/l

0.64

461

(3012516) Albumin [Mass/volume] in Urine

642

7233

0.85

3.07

3.3

736.45

357.91

mg/l

0.81

397

4492

(3010838) Calcium [Moles/time] in 24 hour Urine

472

1.54

3.04

1.7

1.9

5.33

5.14

mmol/24h

0.13

406

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

160

1.95

3.04

1.3

1.2

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

625

5514

1.17

3.01

4.9

3.7

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

645

1.46

3.00

2.0

1.6

416.38

308.86

mu/l

1.09

583

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

162

1.92

2.94

1.3

1.2

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

220

1.78

2.93

3.6

2.2

—

(3013293) Extractable nuclear Ab [Presence] in Serum

3.25

2.93

1.2

1.6

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

177

1.87

2.91

1.1

150.30

38.61

mg/l

0.71

149

(3051387) C reactive protein [Mass/volume] in Capillary blood

510

1.50

2.90

3.5

3.9

30.90

25.83

mg/l

0.55

304

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

207

2589

0.78

2.89

1.6

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

2.38

2.89

1.3

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

277

0.36

2.89

1.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.26

2.86

1.2

1.3

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.26

2.86

2.7

2.4

—

(3005033) Fetal Nuchal fold Thickness US

275

0.36

2.85

1.4

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

123

2.04

2.81

1.7

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

3.34

2.81

1.1

72.83

46.07

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

4.45

2.79

1.0

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

285

0.38

2.76

1.4

1.5

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

102

735

1.40

2.71

1.4

253.25

280.57

ug/g

0.77

421

(3019225) pH of Specimen

300

2506

1.22

2.65

8.2

4.3

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.22

2.63

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

581

6522

0.86

2.60

5.4

5.0

4.43

2.74

ug/l

1.65

506

5821

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

4.68

2.59

1.0

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

426

1.51

2.57

1.2

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

233

1903

1.24

2.55

3.9

3.8

104.11

87.35

ng/l

1.18

210

1638

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.61

2.53

2.2

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

2.61

2.53

2.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

342

0.46

2.52

2.2

1.7

—

(3014891) Appearance of Pleural fluid

3.23

2.51

1.0

1.3

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

356

4145

0.84

2.51

1.3

1.2

28.45

11.68

u/ml

1.96

135

1610

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.33

2.48

1.1

85.30

89.19

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

3.82

2.46

1.4

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

3.82

2.46

1.0

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.56

2.44

1.5

1.1

—

(4200892) Spirometry reversibility

140

1790

0.77

2.37

1.5

1.4

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

2.15

2.34

1.1

1.5

2.08

4.09

umol/l

2.72

(3009508) Creatinine [Moles/volume] in Urine

692

7621

0.88

2.33

3.5

3.2

6.77

7.36

mmol/l

3.41

580

6430

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.23

2.27

1.1

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

4.62

2.27

1.0

1.5

59.07

12.62

nmol/l

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.56

2.27

4.8

3.0

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.86

2.20

1.7

1.3

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1513

14369

1.12

2.20

3.3

2.8

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.25

2.17

1.1

1.3

78.33

90.46

—

(3016750) Collection duration of Urine

151

1.80

2.16

2.5

2.1

497.53

489.73

min

0.15

112

(3030313) Adrenal Ab [Titer] in Serum

4.29

2.15

1.2

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

149

0.33

2.14

1.2

1.4

1.52

1.59

g/l

—

149

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

137

1.83

2.13

1.2

1.1

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2578

25353

1.22

2.11

28.9

10.7

26.42

25.92

u/l

0.86

2553

24461

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

615

1.38

2.10

1.1

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

5.01

2.07

1.0

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

301

1.54

2.06

2.0

1.6

60.39

60.41

0.00

185

(4212803) Bone marrow aspirate examination

3.51

2.05

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1180

0.75

2.00

1.6

1.7

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

104

1.93

2.00

1.1

2.1

161.10

155.40

0.10

(3003327) Ova and parasites identified in Stool by Light microscopy

743

1.33

1.98

1.7

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

186

1.67

1.97

1.4

1.5

13.21

12.24

umol/l

0.31

177

(3014051) Protein [Presence] in Urine by Test strip

657

1.35

1.97

3.1

2.5

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.19

1.94

1.1

1.2

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.57

1.94

3.4

2.4

15.75

18.92

umol/l

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

156

1911

0.81

1.89

1.7

1.9

—

(3045424) Erythrocytes [Presence] in Urine

423

1.43

1.89

1.6

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

181

0.44

1.81

1.0

414.00

318.97

ng/l

—

116

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

182

0.44

1.81

1.0

58.00

45.59

ng/l

—

115

(1761868) Lipid panel - Serum or Plasma

769

8294

0.90

1.75

2.8

2.9

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

155

1.68

1.72

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

331

1.46

1.72

1.4

1.1

—

(36660697) Celiac disease serology panel - Serum

152

1845

0.81

1.71

1.1

1.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

103

1.85

1.71

3.3

2.4

—

(3002523) Influenza virus A Ag [Presence] in Specimen

332

1.45

1.70

1.4

1.1

—

(3022621) pH of Urine by Test strip

186

1557

1.21

1.69

3.3

3.0

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

180

0.44

1.68

1.0

751.25

692.21

ng/l

—

112

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.86

1.66

1.1

1.0

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

140

1707

0.81

1.66

2.1

2.4

35.57

23.82

au/ml

—

124

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

359

1.43

1.65

1.2

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

131

0.38

1.62

1.2

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

166

1.63

1.61

1.0

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

388

4333

0.88

1.60

1.3

50.46

35.32

iu/ml

0.65

128

1424

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

3.00

1.58

1.0

1.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

324

0.58

1.56

1.1

5.02

4.00

u/ml

—

157

(3008401) Mugwort IgE Ab [Units/volume] in Serum

310

0.58

1.54

1.1

1.18

1.77

u/ml

—

126

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

233

1.51

1.52

2.1

1.4

39.29

33.21

0.35

140

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

626

1.30

1.50

1.1

1.3

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1205

0.79

1.50

1.0

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

367

1.40

1.49

1.3

1.2

1.63

3.89

u/ml

1.25

113

(4094501) Cardiovascular stress test using bicycle ergometer

698

0.73

1.48

1.0

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

243

0.53

1.48

2.0

1.7

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

393

1.38

1.48

1.2

137.98

41.38

u/l

2.34

340

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

619

1.30

1.47

1.7

1.9

3.97

5.20

iu/l

0.60

217

(3020650) Glucose [Presence] in Urine

2.04

1.43

1.1

1.6

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.31

1.43

1.2

1.6

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

289

0.59

1.41

1.1

1.5

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

238

1.48

1.39

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

198

0.50

1.38

1.3

1.5

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.20

1.37

1.9

1.4

169.44

105.58

ng/l

—

(3050794) Legionella sp Ab [Presence] in Serum

2.61

1.36

1.5

1.0

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.94

1.36

1.0

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.83

1.35

1.3

1.0

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

383

0.65

1.35

1.0

1.1

25.83

1508.78

iu/ml

—

(3000963) Hemoglobin [Mass/volume] in Blood

2605

26312

0.85

1.33

59.6

21.1

122.50

135.00

g/l

267.17

2584

25937

(3006442) Creatine [Moles/volume] in Serum or Plasma

168

1.55

1.31

2.2

1.5

98.19

81.43

umol/l

0.48

168

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

1.74

1.31

1.4

2.3

16.34

100.07

ug/l

0.51

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

145

1715

0.84

1.30

1.6

1.8

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

1.85

1.29

1.1

2.3

196.36

173.00

0.32

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

1.89

1.28

1.5

1.9

0.57

1.25

ug/l

1.68

(3026361) Erythrocytes [#/volume] in Blood

2605

26305

0.85

1.27

59.3

21.0

4.07

4.48

e12/l

219.18

2567

25562

(3035941) MCH [Entitic mass]

2605

26304

0.85

1.26

59.1

20.9

30.47

30.32

4.16

2584

25929

(3010813) Leukocytes [#/volume] in Blood

2605

26303

0.85

1.25

59.4

21.0

5.94

6.67

e9/l

35.95

2566

25566

(3024731) MCV [Entitic volume]

2605

26300

0.86

1.23

59.1

21.0

92.07

91.13

19.54

2584

25928

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

297

1.39

1.20

1.4

738.53

328.45

pmol/l

0.68

256

(3017446) Testosterone [Moles/volume] in Serum or Plasma

163

1400

1.17

1.19

2.4

2.2

11.12

12.61

nmol/l

1.46

149

1237

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.31

1.18

1.2

1.4

—

(3044009) aPTT.lupus sensitive (LA screen)

2.31

1.18

1.0

1.2

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

125

1.60

1.17

1.3

1.4

22.05

24.68

umol/l

0.16

118

(3007461) Platelets [#/volume] in Blood

2605

26293

0.86

1.17

59.5

21.0

226.18

253.00

e9/l

58.25

2570

25634

(3004775) Volume in Urine collected for unspecified duration

198

1.47

1.16

2.4

2.2

805.41

634.97

1.25

136

(3005322) IgE [Units/volume] in Serum or Plasma

174

1505

1.17

1.16

1.3

351.41

205.82

u/ml

0.61

151

1383

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

368

0.68

1.15

1.1

6.42

1.69

u/ml

0.47

191

(3000492) Spirometry study

204

2319

0.87

1.14

1.6

1.5

—

(3000330) Specific gravity of Urine by Test strip

140

1194

1.18

1.12

4.7

3.3

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.00

1.12

11.3

12.1

4.64

5.88

mmol/l

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

195

0.56

1.10

1.6

1.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

317

0.66

1.10

3.2

2.3

46.63

24.25

mg/l

—

(3025130) Human papilloma virus identified in Specimen

305

0.65

1.10

1.5

1.7

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

270

1.38

1.06

3.8

2.5

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

245

1.39

1.05

3.4

3.9

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

121

1.57

1.05

1.3

1.2

—

(3009542) Hematocrit [Volume Fraction] of Blood

2605

26276

0.87

1.04

59.2

21.1

36.92

40.07

138.64

2481

24623

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.27

1.03

1.6

2.6

—

(3001729) Color of Synovial fluid

2.27

1.03

1.2

1.6

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.27

1.03

1.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.06

1.03

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.92

1.02

1.0

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

413

1.29

1.00

1.4

1.3

—

(3048689) Calprotectin [Mass/mass] in Stool

314

2860

1.11

0.98

3.1

2.2

225.46

137.23

ug/g

2.17

262

2268

(3018851) Theophylline [Moles/volume] in Serum or Plasma

0.00

0.97

0.0

1.8

—

44.00

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.95

0.97

1.1

—

(3023410) Appearance of Cerebral spinal fluid

251

1.36

0.94

3.3

1.5

—

(3019174) dRVVT (LA screen)

2.22

0.93

1.0

1.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.22

0.93

1.0

1.2

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.73

0.92

1.4

1.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

101

855

1.19

0.92

1.5

1.4

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

518

1.24

0.91

1.2

7.88

4.17

u/ml

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

185

1.41

0.89

1.2

1.1

104.00

122.35

titre

—

(3024928) Oxygen saturation in Venous blood

502

1.24

0.88

3.6

2.9

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.65

0.88

1.1

—

(3021788) Differential panel - Synovial fluid

440

1.26

0.87

1.9

1.6

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

103

1.56

0.87

1.0

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

281

1.32

0.86

1.6

1.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

492

0.77

0.85

3.8

1.8

1.12

0.82

nmol/l

1.22

404

(3034891) Synovial lining cells/100 cells in Synovial fluid

121

1.49

0.82

2.0

1.3

4.00

4.09

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.88

0.81

1.0

1.2

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.88

0.81

1.0

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

216

1957

1.11

0.78

3.0

2.8

158.53

180.09

ng/l

0.44

199

1769

(40768443) Skin Pathology biopsy report

121

1059

1.15

0.76

1.2

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.77

0.76

1.2

1.1

—

(3000285) Sodium [Moles/volume] in Blood

1.77

0.76

1.3

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

107

1.50

0.76

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

290

0.72

0.75

1.0

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.09

0.74

8.0

2.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

360

1.25

0.74

1.2

3.06

4.99

u/ml

0.99

146

(3027456) Digoxin [Moles/volume] in Serum or Plasma

451

1.22

0.73

3.1

3.2

0.96

0.82

nmol/l

0.50

353

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.00

0.72

11.0

4.7

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

142

1.41

0.72

1.1

1.23

1.10

u/l

—

(3028707) Methadone [Presence] in Urine by Screen method

274

1.28

0.69

6.6

2.6

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

195

1.34

0.69

1.7

2.1

1.50

2.05

u/field

0.48

(3008037) Lactate [Moles/volume] in Venous blood

501

1.20

0.68

4.0

3.1

1.55

1.53

mmol/l

0.04

483

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.85

0.68

1.0

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

161

1.37

0.68

2.6

2.3

—

(3051593) INR in Capillary blood by Coagulation assay

117

0.60

0.68

11.1

13.5

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.79

0.66

1.0

2.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

912

0.86

0.63

1.7

1.6

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

645

1.17

0.63

1.2

3.99

3.06

u/ml

0.17

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

1.67

0.61

1.4

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.50

0.59

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

114

1276

0.89

0.59

2.2

2.4

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.53

0.59

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

288

0.76

0.59

1.0

3.44

1.52

u/ml

0.29

145

(3000034) Microalbumin [Mass/volume] in Urine

219

1.28

0.58

3.5

2.9

56.24

30.57

mg/l

0.53

155

(4034850) Laboratory test

766

0.86

0.58

12.4

9.7

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

132

1.37

0.57

1.6

1.4

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.67

0.56

1.2

1.1

—

(3011648) Oxygen content in Venous blood

194

1.29

0.55

2.4

1.9

9.22

11.04

1.32

194

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

654

1.15

0.55

1.2

1.3

16.61

7.10

u/ml

0.48

114

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.49

0.53

1.1

—

(3036180) Methadone [Presence] in Urine

1.49

0.53

1.2

1.8

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.54

0.53

1.0

1.2

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

132

0.68

0.51

2.0

1.5

14.30

8.68

ug/l

—

114

(40768800) Prostate Pathology biopsy report

424

0.82

0.51

1.1

1.2

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

292

0.79

0.51

1.3

8.94

7.45

mmol/l

1.03

253

(3044941) Cell count panel - Synovial fluid

401

0.82

0.50

1.4

1.5

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.46

0.50

1.0

1.2

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

145

1.31

0.48

2.2

1.5

7.86

6.63

u/l

0.21

124

(3014271) Vancomycin [Susceptibility]

110

1.37

0.48

2.4

2.8

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

653

1.14

0.48

1.6

1.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

128

1.33

0.47

1.2

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

188

0.74

0.47

2.1

1.5

0.85

0.96

g/l

1.05

188

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

418

3991

1.06

0.46

1.5

1.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

320

3032

1.06

0.46

17.5

6.7

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

1.40

0.44

1.6

2.7

52.57

164.86

umol/l

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

129

0.70

0.43

1.3

1.5

133.48

168.68

pmol/l

—

129

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.43

0.41

1.0

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.38

0.41

14.3

8.4

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.41

0.0

1.1

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.18

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

1.1

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

2.17

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

183

0.76

0.40

1.3

1.2

0.01

0.88

u/ml

—

101

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

141

1.28

0.40

1.2

1.4

—

67.50

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

141

1.28

0.40

1.1

12.18

11.95

iu/ml

—

(3017704) Immunofixation for Urine

150

1.27

0.40

2.2

1.7

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

0.03

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

0.00

0.39

0.0

1.0

—

0.02

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

142

1.27

0.38

1.1

—

(3003129) Base excess in Capillary blood by calculation

1.34

0.38

2.3

1.7

1.09

0.86

mmol/l

—

(3006462) Nitrate [Presence] in Urine

113

0.71

0.37

2.4

3.3

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

347

1.15

0.35

1.0

1.1

—

(3002619) Bacteria identified in Specimen by Culture

1.43

0.35

1.0

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

210

0.81

0.33

2.2

1.6

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

0.70

0.33

6.3

2.9

24.17

30.13

umol/l

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

183

1.20

0.31

1.5

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

183

1.20

0.31

1.5

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

230

0.82

0.31

1.1

1.25

3.59

u/ml

—

(3008898) HLA-B27 [Presence]

789

0.91

0.31

1.0

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.35

0.31

13.0

8.6

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

184

1.20

0.30

1.5

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.33

0.30

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

477

1.11

0.29

4.9

2.0

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

185

1.19

0.29

1.5

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

185

1.19

0.29

1.5

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

185

1.19

0.29

1.5

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

153

1619

0.94

0.29

1.2

113.93

153.90

iu/ml

0.89

619

(3002079) Sodium [Moles/time] in 24 hour Urine

116

0.78

0.27

1.1

1.3

153.44

162.82

mmol/24h

—

116

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

247

0.85

0.27

2.7

4.6

143.50

63.48

u/ml

—

(3006653) Thiamine [Moles/volume] in Blood

128

0.78

0.26

1.2

1.3

115.30

138.26

nmol/l

—

128

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

997

0.93

0.26

1.5

1.8

—

(3029075) Extractable nuclear Ab panel - Serum

1.19

0.26

1.1

1.0

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

246

0.85

0.26

1.0

3.15

2.76

u/ml

—

107

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

703

1.08

0.26

1.2

28.41

34.97

u/ml

—

(3034426) Prothrombin time (PT)

1.22

0.25

1.1

1.2

—

(3049717) Cytology report of Urine Cyto stain

928

1.07

0.24

2.9

2.5

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.32

0.23

1.4

1.3

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.32

0.23

1.0

1.6

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

640

0.92

0.23

1.1

5.96

4.64

u/ml

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.17

—

(3013762) Body weight Measured

0.00

0.21

0.0

1.3

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

996

9825

1.02

0.20

1.9

2.0

90.31

95.72

pmol/l

3.14

616

4971

(3001556) Androgen free Index in Serum or Plasma

0.00

0.20

0.0

1.2

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

12.49

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

275

2675

1.03

0.17

1.9

1.8

1.47

0.01

234

2340

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1871

18597

1.02

0.17

4.6

4.1

14.93

14.80

pmol/l

1.34

1736

16920

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

0.75

0.17

1.2

1.1

164.80

281.22

pmol/l

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

340

1.09

0.16

1.0

1.2

—

(3028300) Cannabinoids [Presence] in Urine

612

1.06

0.16

4.4

2.0

—

(3016879) Cocaine [Presence] in Urine

564

1.07

0.16

4.5

2.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.76

0.15

2.0

1.7

—

(3011288) Drugs identified in Urine by Screen method

410

1.07

0.15

4.0

2.8

—

(3000764) Benzodiazepines [Presence] in Urine

607

1.06

0.13

4.3

2.0

—

(3038515) Glucose [Moles/volume] in Venous blood

471

1.06

0.13

4.5

3.2

7.03

7.45

mmol/l

0.67

456

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

185

1900

0.97

0.13

1.3

1.4

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

323

0.93

0.12

1.1

1.0

2.80

2.48

u/ml

—

136

(1761482) Bacteria [#/volume] in Urine by Culture

573

1.05

0.11

5.5

4.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

134

1.12

0.11

1.0

—

(3005570) Glucose [Moles/volume] in Urine

239

0.92

0.10

1.9

2.0

—

(3044927) Protein electrophoresis panel - Urine

251

1.08

0.10

1.2

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

125

1.12

0.10

1.5

1.3

7.00

5.99

mmol/l

0.66

117

(3015183) Erythrocyte sedimentation rate

114

0.88

0.09

1.0

1.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

124

0.89

0.09

1.1

1.3

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

321

1.06

0.09

1.8

1.3

—

nmol/l

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

727

1.03

0.07

1.8

—

(3022689) Creatine [Moles/volume] in Urine

0.82

0.07

1.7

1.5

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.86

0.07

2.3

1.6

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.07

0.07

1.0

1.1

—

(3027008) Opiates [Presence] in Urine

610

1.03

0.07

4.3

2.0

—

(3004616) Nuclear Ab [Presence] in Serum

315

1.05

0.06

1.3

1.2

—

(3027944) Amphetamines [Presence] in Urine

602

1.03

0.06

4.4

1.9

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

337

1.04

0.05

1.8

1.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

776

0.98

0.04

1.4

1.7

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

368

1.03

0.04

1.1

1.3

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

589

1.02

0.02

2.8

2.3

161.36

113.17

ug/min

0.48

356

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

383

1.02

0.01

2.0

1.7

—

(3000475) Leukocytes [#/volume] in Synovial fluid

607

0.99

0.01

1.9

1.7

18167.37

11913.82

e6/l

0.46

441

(3032773) Endomysium IgG Ab [Titer] in Serum

194

1.03

0.00

1.0

1.1

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

522

5214

1.00

0.00

1.3

1.04

1.59

u/ml

0.95

156

1379

(44813793) Dust mix specific IgE antibody measurement

155

0.97

0.00

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

195

0.97

0.00

1.9

2.0

34.21

5.92

umol/l

0.79

135

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

111

0.99

0.00

2.1

2.4

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

511

1.00

0.00

1.2

68.33

46.52

u/ml

—

(3024263) Appearance of Synovial fluid

126

1.03

0.00

1.4

1.5

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

166

1.02

0.00

2.8

6.3

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

168

1.01

0.00

1.8

1.6

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

242

0.99

0.00

1.3

1.4

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

248

1.01

0.00

2.5

2.2

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

368

1.01

0.00

1.7

1.3

0.14

0.40

nmol/l

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

798

1.00

0.00

1.6

1.5

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

-0.00

0.0

1.0

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

0.98

-0.00

1.2

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.6

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.86

-0.00

1.0

1.1

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

-0.00

0.0

8.0

—

74.80

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.5

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.4

—

2.43

—

(3042301) Urate [Moles/volume] in Synovial fluid

0.00

-0.00

0.0

1.0

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

-0.00

0.0

5.6

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

266.43

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

1308.00

—

Mortality – FinRegistry

↥

Association

Association between endpoint DRUGADVERS_NEUTROPENIA and mortality.

Females

Parameter	HR [95% CI]	p-value
DRUGADVERS_NEUTROPENIA	8.726 [7.5, 10.15]	< 0.001
Birth year	0.992 [0.98, 1.0]	0.057

During the follow-up period (1.1.1998 — 31.12.2019), 2730 out of 6944 females with DRUGADVERS_NEUTROPENIA died.

Males

Parameter	HR [95% CI]	p-value
DRUGADVERS_NEUTROPENIA	9.331 [7.49, 11.63]	< 0.001
Birth year	0.988 [0.98, 1.0]	0.013

During the follow-up period (1.1.1998 — 31.12.2019), 2303 out of 4090 males with DRUGADVERS_NEUTROPENIA died.

Mortality risk

Mortality risk for people of age

years, who have DRUGADVERS_NEUTROPENIA.

N-year risk	Females	Males
1	0.721%	1.851%
5	4.66%	10.622%
10	11.24%	23.446%
15	20.101%	40.366%
20	32.103%	60.541%

Relationships between endpoints

↥

Index endpoint: DRUGADVERS_NEUTROPENIA – Drug-induced neutropenia

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Drug-induced neutropenia

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints